Photoactive compounds for vapor deposited stable organic photovoltaic devices
Photoactive compounds with specific molecular structures address the limitations of current organic photovoltaic devices by offering stability and efficient solar energy harnessing in transparent solar cells, overcoming mechanical flexibility and cost issues through their unique absorption profiles and deposition methods.
Patent Information
- Application Number
- PCT/US2024/025678
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-31
- Filing Date
- 2024-04-22
- Publication Date
- 2024-12-05
AI Technical Summary
Current organic photovoltaic devices face limitations in mechanical flexibility, high module cost, and band-like absorption, making them unsuitable for transparent solar cells, especially for window glass applications, where they are desired for harnessing solar energy efficiently.
Development of photoactive compounds with specific molecular structures, such as D-A-A or D-pi-A arrangements, which can be used as electron donor or acceptor molecules, exhibiting strong absorption in near-infrared and ultraviolet regions while minimizing visible light absorption, allowing for their use in visibly transparent, partially transparent, or opaque photovoltaic devices. These compounds are stable and suitable for vapor deposition techniques, ensuring long-term performance.
The photoactive compounds provide exceptional stability and performance in photovoltaic devices, maintaining optical and electrical properties over long durations, with stability up to five to ten times that of comparable compositions, and enable the creation of transparent solar cells that can efficiently harness solar energy without significant visible light absorption.
Smart Images

Figure IMGF000013_0001 
Figure IMGF000044_0001 
Figure IMGF000046_0001
Abstract
Description
PHOTOACTIVE COMPOUNDS FOR VAPOR DEPOSITED STABLE ORGANIC PHOTOVOLTAIC DEVICES CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of and priority to U.S. Provisional Application No. 63 / 470,166 filed on May 31, 2023, which is hereby incorporated by reference in its entirety. FIELD
[0002] This application relates generally to the field of optically active materials and devices, and, more particularly, to photoactive materials for use in organic photovoltaic devices, photovoltaic devices, and methods for making photovoltaic devices. BACKGROUND
[0003] The surface area necessary to take advantage of solar energy remains an obstacle to offsetting a significant portion of non-renewable energy consumption. For this reason, low-cost, transparent, organic photovoltaic (OPV) devices that can be integrated onto window panes in homes, skyscrapers, and automobiles are desirable. For example, window glass utilized in automobiles and architecture are typically 70-80% and 55-90% transmissive, respectively, to the visible spectrum, e.g., light with wavelengths from about 450 to 650 nanometers (nm). The limited mechanical flexibility, high module cost and, more importantly, the band-like absorption of inorganic semiconductors limit their potential utility to transparent solar cells.
[0004] In contrast, the optical characteristics of organic and molecular semiconductors results in absorption spectra that are highly structured with absorption minima and maxima that are uniquely distinct from the band absorption of their inorganic counterparts. However, a variety of organic and molecular semiconductors exist, but many of these exhibit strong absorption in the visible spectrum and thus are not optimal for use in window glass-based photovoltaics. SUMMARY
[0005] Described herein are materials, methods, and systems related to organic photovoltaic devices and, in some cases, especially useful for visibly transparent organic photovoltaic devices as well as partially transparent organic photovoltaic devices and opaque organic photovoltaicdevices. More particularly, the present description provides photoactive compounds, such as useful as acceptor molecules or donor molecules, and methods and systems incorporating the disclosed compounds as a photoactive material of a photovoltaic device.
[0006] In some examples, the disclosed photoactive compounds comprise molecular or organic semiconductors. The disclosed photoactive compounds include various classes based around or derived from donor (D) and acceptor (A) moieties, in a particular arrangement as D-A-A, with optional pi-bridging moieties between the D and / or A moieties. In some examples, these various moieties may be selected so as to provide an absorption and electrochemical character suitable for use as an electron donor molecule or an electron acceptor in an organic photovoltaic device. In some examples, the photoactive compounds may be arranged in a photoactive layer or a photovoltaic device as a component of one or more mixed photoactive layers or separate photoactive layers. Optionally, such photoactive layers may comprise one or more crystalline layers. Optionally, the photoactive compounds (e.g., an electron donor molecule and / or an electron acceptor molecule) may represent the entirety or substantially the entirety (e.g., greater than 99%) of the photoactive layers in a photovoltaic device, whether in separate or mixed layers. In another example, the photoactive layers may comprise, consist of, or consist essentially of one or more photoactive compounds, such as an electron acceptor molecule and / or an electron donor molecule.
[0007] The disclosed photoactive compounds may be suitable for purification using an evaporation-based technique and / or for deposition on a surface using a vacuum deposition process, like thermal evaporation. In some examples, the photoactive compounds may be characterized by or exhibit a vapor pressure between 10-6Torr and 1 Torr at temperatures from 150 °C to 400 °C. In photovoltaic devices where the photoactive compounds are used in photoactive layers, the photoactive layers may comprise evaporation deposited layers or layers that are not deposited using solution processing.
[0008] In some examples, the disclosed photoactive compounds have the formula D–A1–A2, D–pi–A1–A2, D–A1–pi–A2, or D–pi–A1–pi–A2, where A1and A2are electron acceptor moieties, such as where A2is an aryl-fused cyclopentadione-type group, where D is an electron donormoiety, and where pi is a π-bridging moiety. In examples, A2comprises or , where each Y1is independently C(CN)2, O, S, or cyanoimine, Y2is CH or N, Ar is an aromatic, heteroaromatic, fused-ring aromatic, or fused-ring heteroaromatic group having one or more substituents R, and each R may be H, F, Cl, Br, I, CH3, CF3, CF2H, CFH2, CCl3, or CN. Optionally, A2may be or comprise a substituted or unsubstituted indandione, a substituted or unsubstituted indandithione, a substituted or unsubstituted dicyanomethyleneindanone, or a substituted or unsubstituted bis(dicyanomethylidene)indan. Specific examples of A1, A2, and D are described elsewhere herein.
[0009] In some examples, the disclosed photoactive compounds exhibit exceptional stability and performance, such as when incorporated as a photoactive material in a photovoltaic device. For example, the photoactive compounds may exhibit stability sufficient for use in a photovoltaic device that is exposed to incident solar radiation for many hours without exhibiting photobleaching or other photodegradation that may result in decreased performance of the photovoltaic device. For example, the disclosed photoactive compounds, when incorporated into a photovoltaic device may exhibit stability and good device performance over long periods of time, such as orders of magnitude longer than comparable devices incorporating other photoactive compounds. In some specific examples, the disclosed photoactive compounds, when incorporated into a photovoltaic device may exhibit stability in excess of 5-10 times the stability of other state-of-the-art photoactive organic photovoltaic compositions.
[0010] The disclosed photoactive compounds may be suitable for deposition using vacuum deposition techniques like thermal evaporation. In some cases, the molecular weight of the photoactive compounds may impact the volatility of the compounds, as compounds that have a very high molecular weight may end up thermally decomposing before they evaporate, sublime, or volatilize. In some examples, an upper limit on the molecular weight of a photoactive compound may be about 1200 atomic mass units or about 900 atomic mass units. In some examples, the photoactive compound is characterized by or exhibits a decomposition rate at particular temperature that is lower than an evaporation or sublimation rate at the particulartemperature, such as where the particular temperature is from 150 °C to 400 °C. In some examples, the photoactive compounds may be characterized by or exhibit decomposition rates at temperatures from 150 °C to 400 °C that are lower than the evaporation or sublimation rate at the same temperature. In some examples, the decomposition rates of the photoactive compound at temperatures from 150 °C to 400 °C may be about 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% of the evaporation or sublimation rate at the same temperature. In some examples, the decomposition rates of the photoactive compound at temperatures from 150 °C to 400 °C may be from 1% to 2%, from 2% to 3%, from 3% to 4%, from 4% to 5%, from 5% to 6%, from 6% to 7%, from 7% to 8%, from 8% to 9%, from 9% to 10%, from 11% to 12%, from 12% to 13%, from 13% to 14%, from 14% to 15%, from 15% to 16%, from 16% to 17%, from 17% to 18%, from 18% to 19%, from 19% to 20%, from 21% to 22%, from 22% to 23%, from 23% to 24%, from 24% to 25%, from 25% to 26%, from 26% to 27%, from 27% to 28%, from 28% to 29%, from 29% to 30%, from 31% to 32%, from 32% to 33%, from 33% to 34%, from 34% to 35%, from 35% to 36%, from 36% to 37%, from 37% to 38%, from 38% to 39%, from 39% to 40%, from 41% to 42%, from 42% to 43%, from 43% to 44%, from 44% to 45%, from 45% to 46%, from 46% to 47%, from 47% to 48%, from 48% to 49%, from 49% to 50%, from 51% to 52%, from 52% to 53%, from 53% to 54%, from 54% to 55%, from 55% to 56%, from 56% to 57%, from 57% to 58%, from 58% to 59%, from 59% to 60%, from 61% to 62%, from 62% to 63%, from 63% to 64%, from 64% to 65%, from 65% to 66%, from 66% to 67%, from 67% to 68%, from 68% to 69%, from 69% to 70%, from 71% to 72%, from 72% to 73%, from 73% to 74%, from 74% to 75%, from 75% to 76%, from 76% to 77%, from 77% to 78%, from 78% to 79%, from 79% to 80%, from 81% to 82%, from 82% to 83%, from 83% to 84%, from 84% to 85%, from 85% to 86%, from 86% to 87%, from 87% to 88%, from 88% to 89%, from 89% to 90%, from 91% to 92%, from 92% to 93%, from 93% to 94%, from 94% to 95%, from 95% to 96%, from 96% to 97%, from 97% to 98%, or from 98% to 99% of the evaporation or sublimation rate at the same temperature.
[0011] Photovoltaic devices incorporating the photoactive compounds, methods of making the photoactive compounds, and methods of making photovoltaic devices incorporating the photoactive compounds are also described herein.
[0012] These and other embodiments and aspects of the invention along with many of its advantages and features are described in more detail in conjunction with the text below and attached figures. BRIEF DESCRIPTION OF THE DRAWINGS
[0013] FIG.1 provides a schematic representation of photoactive compounds in accordance with some examples.
[0014] FIG.2A and FIG.2B provide schematic representations of photoactive compounds in accordance with some examples.
[0015] FIG.3A is a simplified schematic diagram illustrating a visibly transparent photovoltaic device according to some examples.
[0016] FIG.3B provides an overview of various configurations of photoactive layer(s) in visibly transparent photovoltaic devices according to some examples.
[0017] FIG.4 is a simplified plot illustrating the solar spectrum, human eye sensitivity, and exemplary transparent photovoltaic device absorption as a function of wavelength.
[0018] FIG.5 is a simplified energy level diagram for a visibly transparent photovoltaic device according to some examples.
[0019] FIG.6A, FIG.6B, FIG.6C, and FIG.6D provide plots showing example absorption profiles for different electron acceptor and electron donor configurations, which can comprise the photoactive layers.
[0020] FIG.7 provides an overview of a method for making a photovoltaic device in accordance with some examples.
[0021] FIG.8 provides a synthetic scheme for preparation of three example photoactive compounds.
[0022] FIG.9 provides a synthetic scheme for preparation of an example compound.
[0023] FIG.10 provides a synthetic scheme for preparation of an example compound.
[0024] FIG.11 provides a synthetic scheme for preparation of a sixth example photoactive compound.
[0025] FIG.12 provides a synthetic scheme for preparation of an example compound.
[0026] FIG.13A provides a synthetic scheme for preparation of three example photoactive compounds.
[0027] FIG.13B provides a synthetic scheme for preparation of two example photoactive compounds.
[0028] FIG.14 provides a synthetic scheme for preparation of two example photoactive compounds.
[0029] FIG.15 provides a synthetic scheme for preparation of three example photoactive compounds.
[0030] FIG.16 provides a synthetic scheme for preparation of three example photoactive compounds.
[0031] FIG.17A, FIG.17B, and FIG.17C provide solution and film spectra for example photoactive compounds.
[0032] FIG.18A, FIG.18B, and FIG.18C provide solution and film spectra for example photoactive compounds.
[0033] FIG.19A and FIG.19B provide solution and film spectra for example photoactive compounds.
[0034] FIG.20A, FIG.20B, and FIG.20C provide schematic depictions of device stack configurations for various comparative devices.
[0035] FIG.21A and FIG.21B provide schematic depictions of device stack configurations for various example devices.
[0036] FIG.22 provides data showing normalized short circuit current (JSC) curves for various comparative devices over time.
[0037] FIG.23 provides data showing normalized short circuit current (JSC) curves for various example devices over time.
[0038] FIG.24 provides data showing normalized open circuit voltage (VOC) curves for various comparative devices over time.
[0039] FIG.25 provides data showing normalized open circuit voltage (VOC) curves for various example devices over time.
[0040] FIG.26 provides data showing normalized fill factor (FF) curves for various comparative devices over time.
[0041] FIG.27 provides data showing normalized fill factor (FF) curves for various example devices over time.
[0042] FIG.28 provides data showing normalized power conversion efficiency (PCE) curves for various comparative devices over time.
[0043] FIG.29 provides data showing normalized power conversion efficiency (PCE) curves for various example devices over time.
[0044] FIG.30A, FIG.30B, and FIG.30C provide data showing current-voltage (J-V) curves for various comparative devices at different times.
[0045] FIG.31A and FIG.31B provide data showing current-voltage (J-V) curves for various example devices at different times.
[0046] FIG.32 provides a synthetic scheme for preparation of an example compound.
[0047] FIG.33 provides a synthetic scheme for preparation of an example compound.
[0048] FIG.34 provides a synthetic scheme for preparation of an example compound.
[0049] FIG.35 provides a synthetic scheme for preparation of an example compound.
[0050] FIG.36 provides a synthetic scheme for preparation of an example compound.
[0051] FIG.37 provides a synthetic scheme for preparation of an example compound.
[0052] FIG.38 provides a synthetic scheme for preparation of an example compound.
[0053] FIG.39 provides a synthetic scheme for preparation of an example compound.
[0054] FIG.40 provides a synthetic scheme for preparation of an example compound.
[0055] FIG.41 provides a synthetic scheme for preparation of an example compound.
[0056] FIG.42 provides a synthetic scheme for preparation of an example compound.
[0057] FIG.43 provides a synthetic scheme for preparation of an example compound.
[0058] FIG.44 provides a synthetic scheme for preparation of an example compound.
[0059] FIG.45 provides a synthetic scheme for preparation of four example photoactive compounds.
[0060] FIG.46 provides a synthetic scheme for preparation of four example photoactive compounds.
[0061] FIG.47 provides a synthetic scheme for preparation of three example photoactive compounds.
[0062] FIG.48 provides a synthetic scheme for preparation of two example photoactive compounds. DETAILED DESCRIPTION
[0063] The present disclosure relates to photoactive compounds, which may be useful as electron donor compounds or electron acceptor compounds, photovoltaic devices incorporating the disclosed photoactive compounds as photoactive materials, and methods of making and using photovoltaic devices. The disclosed photoactive compounds possess properties, such as relatively low molecular weights, relatively high vapor pressures, or the like, that allow for the compounds to be purified and / or deposited using vapor phase techniques such as sublimation, thermal evaporation, or vapor deposition. In addition, the photoactive compounds exhibit strong absorption, allowing for use in organic photovoltaic devices. In some cases, the photoactive compounds exhibit absorption of light more strongly in the near-infrared and / or ultraviolet regions and less strongly in the visible region, permitting their use in visibly transparent photovoltaic devices. In other cases, the photoactive compounds are useful in transparent and opaque photovoltaic devices.
[0064] The disclosed photoactive compounds include those with specific features that may provide advantages for use as electron donors, but may also be useful as electron acceptors in some cases depending on the pairing of the photoactive compounds with other compounds in an organic photovoltaic device. The disclosed compounds may exhibit a molecular structure where different moieties, groups, or sub-structures are bonded to or adjoined to one another, such as an electron donor moiety, a first electron acceptor moiety, and a second electron acceptor moiety. These components may be arranged in any suitable arrangement to form a photoactive compound and optionally linked to one another by pi-bridging or linking moieties. Moreover, each of the different components may include certain structural / compositional features that can impact various properties of the photoactive compound, such as the band gap, the vapor pressure at a particular temperature, the evaporation rate at a particular temperature, the decomposition rate at a particular temperature, or the crystal packing density, for example.
[0065] Advantageously, many of the disclosed photoactive compounds exhibit surprising and unexpected long-term stability under illumination, allowing for photovoltaic devices incorporating the photoactive compounds to exhibit stable performances over long durations. Compared to structurally similar photoactive compounds, the disclosed photoactive compounds, in some cases comprising the same or similar donor and / or acceptor moieties, maintain optical and electrical performance, such as by exhibiting a low degradation rate (e.g., due to photodegradation). As photovoltaic devices tend to be placed in areas with high photoexposure (e.g., sunlight exposure for many hours per day), photoactive compound stability is valuable to allow photovoltaic devices comprising such photoactive compounds to exhibit long term utility and meet industry standard longevity (e.g., up to two decades or more).
[0066] FIG.1, FIG.2A, and FIG.2B provide schematic representations of photoactive compounds 100, 200, and 250, respectively and show photoactive compounds 100, 200, and 250 respectively including an electron donor moiety 105, 205, or 255, a first electron acceptor moiety 110, 210, or 260, and a second electron acceptor moiety 115, 215, or 265. Also shown in FIG. 1A and FIG.2A are π-bridging moieties 120, 125, and 225 bonded between the electron donor and acceptor moieties. FIG.2A and FIG.2B also shown aryl or heteroaryl moieties 220, 270, and 275 providing fusing between electron donor moiety 205 and first electron acceptor moiety 210, between electron donor moiety 255 and first electron acceptor moiety 260, and fused to firstelectron acceptor moiety 260 and bonded to second electron acceptor moiety 265. It will be appreciated that π-bridging moieties 120, 125, and 225 and aryl or heteroaryl moieties 220, 270, and 275 are optional, such that one or more of the π-bridging moieties or aryl or heteroaryl moieties may be absent or not included in various photoactive compound embodiments and examples described herein.
[0067] In FIG.1, the electron donor moiety 105, first electron acceptor moiety 110, second electron acceptor moiety 115, and optional π-bridging moieties 120 and 125 are depicted as linked through individual covalent bonds, which may optionally be single covalent bonds or double covalent bonds. In cases where π-bridging moiety 120 is not present, electron donor moiety 105 and first electron acceptor moiety 110 may be linked through an individual covalent bond directly between these moieties. In cases where π-bridging moiety 125 is not present, first electron acceptor moiety 110 and second electron acceptor moiety 115 may be linked through an individual covalent bond directly between these moieties. One or both π-bridging moieties 120 and 125 may be present or not present in various photoactive compound embodiments and examples.
[0068] In FIG.2A, the electron donor moiety 205, optional aryl or heteroaryl moiety 220, and first electron acceptor moiety 210 are shown as a fused structure 230, which is linked to π- bridging moiety 225 and second electron acceptor moiety 215 through individual covalent bonds, which may optionally be single covalent bonds or double covalent bonds. In fused structure 230, the electron donor moiety 205, optional aryl or heteroaryl moiety 220, and first electron acceptor moiety 210 may be linked by multiple covalent bonds and / or share overlapping or common structural components, such as in a fused ring configuration. For example, fused structure 230 may include one or more fused-ring moieties comprising the electron donor moiety 205, optional aryl or heteroaryl moiety 220, and first electron acceptor moiety 210. In cases where aryl or heteroaryl moiety 220 is not present, fused structure 230 may comprise electron donor moiety 205 fused to first electron acceptor moiety 210, such as linked by multiple covalent bonds and / or sharing overlapping or common structural components, such as where fused structure 230 may include a fused-ring moiety comprising the electron donor moiety 205 and first electron acceptor moiety 210. In cases where π-bridging moiety 225 is not present, first electron acceptor moiety 210 and second electron acceptor moiety 215 may be linked through an individual covalent bonddirectly between these moieties. One or both aryl or heteroaryl moiety 220 and π-bridging moiety 225 may be present or not present in various photoactive compound embodiments and examples.
[0069] In FIG.2B, the electron donor moiety 255, optional aryl or heteroaryl moiety 270, first electron acceptor moiety 260, and optional aryl or heteroaryl moiety 275 are shown as a fused structure 280, which is linked to second electron acceptor moiety 265 through an individual covalent bond, which may optionally be a single covalent bond or a double covalent bond. In fused structure 280, the electron donor moiety 255, optional aryl or heteroaryl moiety 270, first electron acceptor moiety 260, and optional aryl or heteroaryl moiety 270 may be linked by multiple covalent bonds and / or share overlapping or common structural components. For example, fused structure 280 may include one or more fused-ring moieties comprising the electron donor moiety 255, optional aryl or heteroaryl moiety 270, first electron acceptor moiety 260, and optional aryl or heteroaryl moiety 275. In cases where aryl or heteroaryl moiety 220 is not present, fused structure 280 may comprise electron donor moiety 205, first electron acceptor moiety 210, and optional aryl or heteroaryl moiety 275 fused together, such as linked by multiple covalent bonds and / or sharing overlapping or common structural components, such as where fused structure 280 may include a fused-ring moiety comprising the electron donor moiety 205, first electron acceptor moiety 210, and aryl or heteroaryl moiety 275. In cases where aryl or heteroaryl moiety 270 is not present, fused structure 280 may comprise electron donor moiety 255, first electron acceptor moiety 260, and optional aryl or heteroaryl moiety 275 fused together, such as linked by multiple covalent bonds and / or sharing overlapping or common structural components, such as where fused structure 280 may include a fused-ring moiety comprising the electron donor moiety 255, first electron acceptor moiety 260, and optional π- bridging moiety 275. In cases where π-bridging moiety 275 is not present, fused structure 280 may comprise electron donor moiety 255, optional π-bridging moiety 275, and first electron acceptor moiety 260 fused together, such as linked by multiple covalent bonds and / or sharing overlapping or common structural components, such as where fused structure 280 may include a fused-ring moiety comprising the electron donor moiety 255, optional π-bridging moiety 270, and first electron acceptor moiety 260. In cases where both aryl or heteroaryl moiety 270 and aryl or heteroaryl moiety 275 are not present, fused structure 280 may comprise electron donor moiety 255 and first electron acceptor moiety 260 fused together, such as linked by multiplecovalent bonds and / or sharing overlapping or common structural components, such as where fused structure 280 may include a fused-ring moiety comprising the electron donor moiety 255 and first electron acceptor moiety 260, with fused structure 280 and second electron acceptor moiety 215 linked through an individual covalent bond directly between these moieties. In cases where aryl or heteroaryl moiety 275 is not present, first electron acceptor moiety 260 and second electron acceptor moiety 265 may be linked through an individual covalent bond directly between these moieties. One or both aryl or heteroaryl moieties 270 and 275 may be present or not present in various photoactive compound embodiments and examples.
[0070] In some examples, the electron donor moiety 105, 205, or 255 may comprise a diarylamine, aromatic, heteroaromatic, polycyclic aromatic, or polycyclic heteroaromatic moiety including one or more 5-membered rings, one or more 6-membered rings, or a combination of one or more 5-membered rings and one or more 6-membered rings. In some examples, the first electron acceptor moiety 110, 210, or 260 may comprise a fused heteroaromatic ring moiety. In some examples, the second electron acceptor moiety 115, 215, or 265 may comprise an aryl- fused cyclopentadione group, such as having a formul ere each Y1is independently C(CN)2, O, S, or cyanoimine, Y2is Croaromatic, fused-ring aromatic, or fused-ring heteroaromatic group having one or more substituents R, and each R may be H, F, Cl, Br, I, CH3, CF3, CF2H, CFH2, CCl3, or CN. In some examples, the second electron acceptor moiety 115, 215, or 265 may be or comprise a substituted or unsubstituted indandione, a substituted or unsubstituted indandithione, a substituted or unsubstituted dicyanomethyleneindanone, or a substituted or unsubstituted bis(dicyanomethylidene)indan. In some examples, the π-bridging moiety 120, 125, or 225 may comprise a conjugated group, such as an aryl, heteroaryl, fused aryl, or fused heteroaryl group. In some examples, the aryl or heteroaryl moiety 220, 270, or 275 may comprise or provide aromatic or heteroaromatic linking between or to adjacent electron donor moieties or first electron acceptor moieties
[0071] In photoactive compounds 100, 200, and 250 described above, a variety of substitutions may be made for one or more hydrogen atoms in the compounds and moieties described herein.In examples, one or more of the electron donor moiety 105, 205, or 255, the first electron acceptor moiety 110, 210, or 260, the second electron acceptor moiety 115, 215, or 265, the π- bridging moiety 120, 125, or 225, or the aryl or heteroaryl moiety 220, 270, or 275 may include one or more non-hydrogen substituents, such as a cyano group, a halo group (e.g., -F, -Cl, -Br, - I), an alkyl group, a cycloalkyl group, an alkenyl group, a cycloalkenyl group, an aryl group, a heteroaryl group, or a fused ring group, any of which may optionally be substituted with one or more halogens or cyano groups. Example non-hydrogen substituents may further include, but are not limited, a straight, branched, or cyclic alkyl, fluorinated alkyl, or alkylene group having a molecular weight of from 15 amu to 150 amu (e.g., 15 amu to 25 amu, 25 to 50 amu, 50 amu to 75 amu, 75 amu to 100 amu, 100 amu to 125 amu, or 125 amu to 150 amu), a halogen, CN, CX3, where X is a halogen, an Ar group, where Ar is an aromatic or fused aromatic ring or a heterocyclic or fused heterocyclic ring containing N, S, or O, and having one or more substituents selected from H, a halogen, CN, CX3, where X is a halogen, or a straight, branched, or cyclic alkyl, fluorinated alkyl, or alkylene group having a molecular weight of from 15 amu to 150 amu (e.g., 15 amu to 25 amu, 25 to 50 amu, 50 amu to 75 amu, 75 amu to 100 amu, 100 amu to 125 amu, or 125 amu to 150 amu).
[0072] In some examples, for purification and use of the disclosed photoactive compounds, a very high molecular weight may be undesirable, such as about 1200 amu or higher, about 1150 amu or higher, about 1100 amu or higher, about 1050 amu or higher, about 1000 amu or higher, about 950 amu or higher, about 900 amu or higher, or between 900 amu and 2000 amu or a subrange thereof. Some compounds with very high molecular weights may have limited volatilities and useful methods of purifying and using photoactive compounds may employ an evaporation- or sublimation-based method. In addition, the photoactive compounds may be deposited as part of a photovoltaic device using a thermal evaporation technique and compounds of very high molecular weight may be difficult to deposit using thermal evaporation. In various examples, the photoactive compounds described herein have a molecular weight of 200 amu to 1200 amu, less than or about 1200, less than or about 1150, less than or about 1100 amu, less than or about 1050 amu, less than or about 1000 amu, less than or about 950 amu, less than or about 900 amu, less than or about 850 amu, less than or about 800 amu, less than or about 750 amu, less than or about 700 amu, less than or about 650 amu, less than or about 600 amu, less than or about 550 amu, less than or about 500 amu, less than or about 450 amu, less than orabout 400 amu, less than or about 350 amu, less than or about 300 amu, less than or about 250 amu, or less than or about 200 amu.
[0073] To achieve desired optical properties, photoactive compounds may exhibit a molecular electronic structure where photons of light are absorbed, which results in promotion of an electron to a higher molecular orbital, with an energy difference matching that of the absorbed photon, which may result in generation of an electron-hole pair or exciton, which can subsequently separate into distinct electrons and holes, such as at an interface with another material. Compounds exhibiting extended aromaticity or extended conjugation may be beneficial, as compounds with extended aromaticity or extended conjugation may exhibit electronic absorption with energies matching that of near-infrared, visible, and / or ultraviolet photons. In addition to conjugation and aromaticity, absorption features may be modulated by inclusion of heteroatoms in the organic structure of the visibly transparent photoactive compounds, such as oxygen, nitrogen, selenium, or sulfur atoms.
[0074] In general the terms and phrases used herein have their art-recognized meaning, which can be found by reference to standard texts, journal references and contexts known to those skilled in the art. The following definitions are provided to clarify their specific use in the context of the invention.
[0075] As used herein, “maximum absorption strength” refers to the largest absorption value in a particular spectral region, such as the ultraviolet band (e.g., from 200 nm to 450 nm or from 280 nm to 450 nm), the visible band (e.g., from 450 nm to 650 nm), or the near-infrared band (e.g., from 650 nm to 1400 nm), or of a particular absorption peak or feature of a particular molecule, for example. In some examples, a maximum absorption strength may correspond to an absorption strength of an absorption feature that is a local or absolute maximum, such as an absorption band or peak, and may be referred to as a peak absorption. In some examples, a maximum absorption strength in a particular band may not correspond to a local or absolute maximum but may instead correspond to the largest absorption value in the particular band. Such a configuration may occur, for example, when an absorption feature spans multiple bands (e.g., visible and near-infrared), and the absorption values from the absorption feature that occur within one band are smaller than those occurring within the adjacent band, such as when the peak of the absorption feature is located within the near-infrared band but a tail of the absorptionfeature extends to the visible band. In some examples, a photoactive compound described herein may have an absorption peak at a wavelength greater than about 600 nm or greater than or about 650 nanometers (e.g., in the red or the near-infrared), and the photoactive compound's absorption for such a peak may be greater in magnitude than the photoactive compound’s absorption at any shorter visible wavelength, such as between about 450 and 650 nanometers.
[0076] In various examples, disclosed compositions or compounds are isolated or purified. Optionally, an isolated or purified compound is at least partially isolated or purified as would be understood in the art. In some examples, a disclosed composition or compound has a chemical purity of 80%, optionally for some applications 90%, optionally for some applications 95%, optionally for some applications 99%, optionally for some applications 99.9%, optionally for some applications 99.99%, and optionally for some applications 99.999% pure. Purification of the disclosed compositions or compounds may be performed using any desirable technique. Purification by evaporation or sublimation and crystallization (e.g., vacuum evaporation or sublimation) may be a useful technique.
[0077] Compounds disclosed herein optionally contain one or more ionizable groups. Ionizable groups include groups from which a proton can be removed (e.g., –COOH) or added (e.g., amines) and groups which can be quaternized (e.g., amines). All possible ionic forms of such molecules and salts thereof are intended to be included individually in the disclosure herein. With regard to salts of the compounds described herein, it will be appreciated that a wide variety of available counter-ions may be selected that are appropriate for preparation of salts for a given application. In specific applications, the selection of a given anion or cation for preparation of a salt can result in increased or decreased solubility of that salt.
[0078] The disclosed compounds optionally contain one or more chiral centers. Accordingly, this disclosure includes racemic mixtures, diastereomers, enantiomers, tautomers and mixtures enriched in one or more stereoisomer. Disclosed compounds including chiral centers encompass the racemic forms of the compound as well as the individual enantiomers and non-racemic mixtures thereof.
[0079] As used herein, the terms “group” and “moiety” may refer to a functional group of a chemical compound. Groups of the disclosed compounds refer to an atom or a collection of atoms that are a part of the compound. Groups of the disclosed compounds may be attached toother atoms of the compound via one or more covalent bonds. Groups may also be characterized with respect to their valence state. The present disclosure includes groups characterized as monovalent, divalent, trivalent, etc. valence states. Optionally, the term “substituent” may be used interchangeably with the terms “group” and “moiety.” Groups may also be characterized with respect to their ability to donate or receive an electron, and such characterization may, in some examples, refer to a relative character of the group to donate or receive an electron as compared to other groups.
[0080] As is customary and well known in the art, hydrogen atoms in chemical formulas disclosed herein are not always explicitly shown, for example, hydrogen atoms bonded to the carbon atoms of aliphatic, aromatic, alicyclic, carbocyclic, and / or heterocyclic rings are not always explicitly shown in the formulas recited. The structures provided herein, for example in the context of the description of any specific formulas and structures recited, are intended to convey the chemical composition of disclosed compounds of methods and compositions. It will be appreciated that the structures provided do not indicate the specific positions of atoms and bond angles between atoms of these compounds.
[0081] As used herein, the terms “alkylene” and “alkylene group” are used synonymously and refer to a divalent group derived from an alkyl group as defined herein. The present disclosure includes compounds having one or more alkylene groups. Alkylene groups in some compounds function as attaching and / or spacer groups. Disclosed compounds optionally include substituted and / or unsubstituted C1-C20alkylene groups, such as C1-C5alkylene, C5-C10alkylene, C10-C15alkylene, or C15-C20 alkylene groups.
[0082] As used herein, the terms “cycloalkylene” and “cycloalkylene group” are used synonymously and refer to a divalent group derived from a cycloalkyl group as defined herein. The present disclosure includes compounds having one or more cycloalkylene groups. Cycloalkyl groups in some compounds function as attaching and / or spacer groups. Disclosed compounds optionally include substituted and / or unsubstituted C3-C20cycloalkylene groups, such as C3-C5 cycloalkylene, C5-C10 cycloalkylene, C15-C20 cycloalkylene, or C15-C20 cycloalkylene groups.
[0083] As used herein, the terms “arylene” and “arylene group” are used synonymously and refer to a divalent group derived from an aryl group as defined herein. The present disclosureincludes compounds having one or more arylene groups. In some examples, an arylene is a divalent group derived from an aryl group by removal of hydrogen atoms from two intra-ring carbon atoms of an aromatic ring of the aryl group. Arylene groups in some compounds function as attaching and / or spacer groups. Arylene groups in some compounds function as chromophore, fluorophore, aromatic antenna, dye, and / or imaging groups. Disclosed compounds optionally include substituted and / or unsubstituted C5-C30arylene groups, such as C5-C10arylene, C10-C15arylene, C15-C20arylene, C20-C25arylene, or C25-C30arylene groups.
[0084] As used herein, the terms “heteroarylene” and “heteroarylene group” are used synonymously and refer to a divalent group derived from a heteroaryl group as defined herein. The present disclosure includes compounds having one or more heteroarylene groups. In some examples, a heteroarylene is a divalent group derived from a heteroaryl group by removal of hydrogen atoms from two intra-ring carbon atoms or intra-ring nitrogen atoms of a heteroaromatic or aromatic ring of the heteroaryl group. Heteroarylene groups in some compounds function as attaching and / or spacer groups. Heteroarylene groups in some compounds function as chromophore, aromatic antenna, fluorophore, dye, and / or imaging groups. Disclosed compounds optionally include substituted and / or unsubstituted C5-C30heteroarylene groups, such as C5-C10heteroarylene, C10-C15heteroarylene, C15-C20heteroarylene, C20-C25 heteroarylene, or C25-C30 heteroarylene groups.
[0085] As used herein, the terms “alkenylene” and “alkenylene group” are used synonymously and refer to a divalent group derived from an alkenyl group as defined herein. The present disclosure includes compounds having one or more alkenylene groups. Alkenylene groups in some compounds function as attaching and / or spacer groups. Disclosed compounds optionally include substituted and / or unsubstituted C2-C20alkenylene groups, such as C2-C5alkenylene, C5- C10 alkenylene, C10-C15 alkenylene, or C15-C20 alkenylene groups.
[0086] As used herein, the terms “cylcoalkenylene” and “cylcoalkenylene group” are used synonymously and refer to a divalent group derived from a cylcoalkenyl group as defined herein. The present disclosure includes compounds having one or more cylcoalkenylene groups. Cycloalkenylene groups in some compounds function as attaching and / or spacer groups. Disclosed compounds optionally include substituted and / or unsubstituted C3-C20cylcoalkenylene groups, such as C3-C5cylcoalkenylene, C5-C10cylcoalkenylene, C10-C15cylcoalkenylene, or C15-C20 cylcoalkenylene groups.
[0087] As used herein, the terms “alkynylene” and “alkynylene group” are used synonymously and refer to a divalent group derived from an alkynyl group as defined herein. The present disclosure includes compounds having one or more alkynylene groups. Alkynylene groups in some compounds function as attaching and / or spacer groups. Disclosed compounds optionally include substituted and / or unsubstituted C2-C20alkynylene groups, such as C2-C5alkynylene, C5- C10alkynylene, C10-C15alkynylene, or C15-C20alkynylene groups.
[0088] As used herein, the term “halo” refers to a halogen group, such as a fluoro (–F), chloro (–Cl), bromo (–Br), or iodo (–I).
[0089] The term “heterocyclic” refers to ring structures containing at least one other kind of atom, in addition to carbon, in the ring. Examples of such atoms include oxygen, sulfur, selenium, tellurium, nitrogen, phosphorus, silicon, germanium, boron, aluminum, and, in some cases, a transition metal. Examples of heterocyclic rings include, but are not limited to, pyrrolidinyl, piperidyl, imidazolidinyl, tetrahydrofuranyl, tetrahydrothienyl, furanyl, thienyl, pyridyl, quinolyl, isoquinolyl, pyridazinyl, pyrazinyl, indolyl, imidazolyl, oxazolyl, thiazolyl, pyrazolyl, pyridinyl, benzoxadiazolyl, benzothiadiazolyl, triazolyl, and tetrazolyl groups, or fusions thereof. Atoms of heterocyclic rings can be bonded to a wide range of other atoms and functional groups, for example, provided as substituents. Heterocyclic rings include aromatic heterocycles and non-aromatic heterocycles.
[0090] The term “carbocyclic” refers to ring structures containing only carbon atoms in the ring. Carbon atoms of carbocyclic rings can be bonded to a wide range of other atoms and functional groups, for example, provided as substituents. Carbocyclic rings include aromatic carbocyclic rings and non-aromatic carbocyclic rings.
[0091] The term “alicyclic” refers to a ring that is not an aromatic ring. Alicyclic rings include both carbocyclic and heterocyclic rings.
[0092] The term “aliphatic” refers to non-aromatic hydrocarbon compounds and groups. Aliphatic groups generally include carbon atoms covalently bonded to one or more other atoms, such as carbon and hydrogen atoms. Aliphatic groups may, however, include a non-carbon atom, such as an oxygen atom, a nitrogen atom, a sulfur atom, etc., in place of a carbon atom.Non-substituted aliphatic groups include only hydrogen substituents. Substituted aliphatic groups include non-hydrogen substituents, such as halo groups and other substituents described herein. Aliphatic groups can be straight chain, branched, or cyclic. Aliphatic groups can be saturated, meaning only single bonds join adjacent carbon (or other) atoms. Aliphatic groups can be unsaturated, meaning one or more double bonds or triple bonds join adjacent carbon (or other) atoms.
[0093] Alkyl groups include straight-chain, branched, and cyclic alkyl groups. Alkyl groups include those having from 1 to 30 carbon atoms, such as from 1 to 5, from 5 to 10, from 10 to 15, from 15 to 20, from 20 to 25, or from 25 to 30 carbon atoms. Alkyl groups include small alkyl groups having 1 to 3 carbon atoms. Alkyl groups include medium length alkyl groups having from 4-10 carbon atoms. Alkyl groups include long alkyl groups having more than 10 carbon atoms, particularly those having 10-30 carbon atoms. The term cycloalkyl specifically refers to an alky group having a ring structure such as ring structure comprising 3-30 carbon atoms, optionally 3-20 carbon atoms and optionally 3-10 carbon atoms, including an alkyl group having one or more rings. Cycloalkyl groups include those having a 3-, 4-, 5-, 6-, 7-, 8-, 9-, or 10- member carbon ring(s) and particularly those having a 3-, 4-, 5-, 6-, or 7-member ring(s). The carbon rings in cycloalkyl groups can also carry alkyl groups. Cycloalkyl groups can include bicyclic and tricycloalkyl groups. Alkyl groups are optionally substituted. Substituted alkyl groups include, among others, those which are substituted with aryl or heteroaryl groups, which in turn can be optionally substituted. Specific alkyl groups include methyl, ethyl, n-propyl, iso- propyl, cyclopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, cyclobutyl, n-pentyl, branched- pentyl, cyclopentyl, n-hexyl, branched hexyl, and cyclohexyl groups, all of which are optionally substituted. Substituted alkyl groups include fully-halogenated or semi-halogenated alkyl groups, such as alkyl groups having one or more hydrogens replaced with one or more fluorine atoms, chlorine atoms, bromine atoms and / or iodine atoms. Substituted alkyl groups include fully-fluorinated or semi-fluorinated alkyl groups, such as alkyl groups having one or more hydrogens replaced with one or more fluorine atoms. Substituted alkyl groups include alkyl groups substituted with one or more methyl, ethyl, halogen (e.g., fluoro), or trihalomethyl (e.g., trifluoromethyl) groups.
[0094] An alkoxy group is an alkyl group that has been modified by linkage to oxygen and canbe represented by the formula R–O and can also be referred to as an alkyl ether group. Examples of alkoxy groups include, but are not limited to, methoxy, ethoxy, propoxy, butoxy, and heptoxy. Alkoxy groups include substituted alkoxy groups wherein the alkyl portion of the groups is substituted as provided herein in connection with the description of alkyl groups. As used herein MeO– refers to CH3O–.
[0095] Alkenyl groups include straight-chain, branched, and cyclic alkenyl groups. Alkenyl groups include those having 1, 2, or more double bonds and those in which two or more of the double bonds are conjugated double bonds. Alkenyl groups include those having from 2 to 20 carbon atoms, such as from 2 to 5, from 5 to 10, from 10 to 15, or from 15 to 10 carbon atoms. Alkenyl groups include small alkenyl groups having 2 to 4 carbon atoms. Alkenyl groups include medium length alkenyl groups having from 5-10 carbon atoms. Alkenyl groups include long alkenyl groups having more than 10 carbon atoms, particularly those having 10-20 carbon atoms. Cycloalkenyl groups include those in which a double bond is in the ring or in an alkenyl group attached to a ring. The term cycloalkenyl specifically refers to an alkenyl group having a ring structure, including an alkenyl group having a 3-, 4-, 5-, 6-, 7-, 8-, 9-, or 10-member carbon ring(s) and particularly those having a 3-, 4-, 5-, 6-, or 7-member ring(s). The carbon rings in cycloalkenyl groups can also carry alkyl groups. Cycloalkenyl groups can include bicyclic and tricyclic alkenyl groups. Alkenyl groups are optionally substituted. Substituted alkenyl groups include among others those which are substituted with alkyl or aryl or heteroaryl groups, which groups in turn can be optionally substituted. Specific alkenyl groups include ethenyl, prop-1- enyl, prop-2-enyl, cycloprop-1-enyl, but-1-enyl, but-2-enyl, cyclobut-1-enyl, cyclobut-2-enyl, pent-1-enyl, pent-2-enyl, branched pentenyl, cyclopent-1-enyl, hex-1-enyl, branched hexenyl, cyclohexenyl, all of which are optionally substituted. Substituted alkenyl groups include fully- halogenated or semi-halogenated alkenyl groups, such as alkenyl groups having one or more hydrogens replaced with one or more fluorine atoms, chlorine atoms, bromine atoms, and / or iodine atoms. Substituted alkenyl groups include fully-fluorinated or semi-fluorinated alkenyl groups, such as alkenyl groups having one or more hydrogen atoms replaced with one or more fluorine atoms. Substituted alkyl groups include alkyl groups substituted with one or more methyl, ethyl, halogen (e.g., fluoro), or trihalomethyl (e.g., trifluoromethyl) groups.
[0096] Aryl groups include groups having one or more 5-, 6- or 7-member aromatic and / orheterocyclic aromatic rings, as well as fused aromatic and / or heteroaromatic rings. The term heteroaryl specifically refers to aryl groups having at least one 5-, 6-, or 7-member heterocyclic aromatic rings. The term aryl may include both carbocyclic aromatic rings and heteroaromatic rings. Aryl or heteroaryl groups can contain one or more fused aromatic and heteroaromatic rings or a combination of one or more aromatic or heteroaromatic rings and one or more non- aromatic rings that may be fused or linked via covalent bonds. Heterocyclic aromatic rings can include one or more N, O, or S atoms in the ring, among others. Heterocyclic aromatic rings can include those with one, two or three N atoms, those with one or two O atoms, and those with one or two S atoms, or combinations of one or two or three N, O, or S atoms, among others. Aryl or heteroaryl groups are optionally substituted. Substituted aryl or heteroaryl groups include among others those which are substituted with alkyl or alkenyl groups, which groups in turn can be optionally substituted. Specific aryl groups include phenyl, biphenyl groups, pyrrolidinyl, imidazolidinyl, tetrahydrofuranyl, tetrahydrothienyl, furanyl, thienyl, pyridyl, quinolyl, isoquinolyl, pyridazinyl, pyrazinyl, indolyl, imidazolyl, oxazolyl, thiazolyl, pyrazolyl, pyridinyl, benzoxadiazolyl, benzothiadiazolyl, and naphthyl groups, all of which are optionally substituted. Substituted aryl or heteroaryl groups include fully halogenated or semi-halogenated aryl or heteroaryl groups, such as aryl or heteroaryl groups having one or more hydrogens replaced with one or more fluorine atoms, chlorine atoms, bromine atoms and / or iodine atoms. Substituted aryl or heteroaryl groups include fully fluorinated or semi-fluorinated aryl or heteroaryl groups, such as aryl or heteroaryl groups having one or more hydrogens replaced with one or more fluorine atoms. Aryl or heteroaryl groups include, but are not limited to, aromatic group- containing or heterocyclic aromatic group-containing groups corresponding to any one of the following: benzene, naphthalene, naphthoquinone, diphenylmethane, fluorene, anthracene, anthraquinone, phenanthrene, tetracene, tetracenedione, pyridine, quinoline, isoquinoline, indoles, isoindole, pyrrole, imidazole, oxazole, thiazole, pyrazole, pyrazine, pyrimidine, purine, benzimidazole, furans, benzofuran, dibenzofuran, carbazole, acridine, acridone, phenanthridine, thiophene, benzothiophene, dibenzothiophene, xanthene, xanthone, flavone, coumarin, azulene, or anthracycline. As used herein, a group corresponding to the groups listed above expressly includes an aromatic or heterocyclic aromatic group, including monovalent, divalent and polyvalent groups, of the aromatic and heterocyclic aromatic groups listed herein are provided in a covalently bonded configuration in the disclosed compounds at any suitable point ofattachment. In examples, aryl groups contain between 5 and 30 carbon atoms, such as from 5 to 10, from 10 to 15, from 15 to 20, from 20 to 25, or from 25 to 30 carbon atoms. In examples, aryl groups contain one aromatic or heteroaromatic six-membered ring and one or more additional five- or six-membered aromatic or heteroaromatic ring. In examples, aryl groups contain between five and eighteen carbon atoms in the rings. Aryl groups optionally have one or more aromatic rings or heterocyclic aromatic rings having one or more electron donating groups, electron withdrawing groups and / or targeting ligands provided as substituents. Substituted alkyl groups include alkyl groups substituted with one or more methyl, ethyl, halogen (e.g., fluoro), or trihalomethyl (e.g., trifluoromethyl) groups.
[0097] Arylalkyl and alkylaryl groups are alkyl groups substituted with one or more aryl or heteroaryl groups wherein the alkyl groups optionally carry additional substituents and the aryl or heteroaryl groups are optionally substituted. Specific alkylaryl groups are phenyl-substituted alkyl groups, e.g., phenylmethyl groups. Alkylaryl and arylalkyl groups are alternatively described as aryl or heteroaryl groups substituted with one or more alkyl groups wherein the alkyl groups optionally carry additional substituents and the aryl or heteroaryl groups are optionally substituted. Specific alkylaryl groups are alkyl-substituted phenyl groups such as methylphenyl. Substituted arylalkyl groups include fully-halogenated or semi-halogenated arylalkyl groups, such as arylalkyl groups having one or more alkyl and / or aryl or heteroaryl groups having one or more hydrogens replaced with one or more fluorine atoms, chlorine atoms, bromine atoms, and / or iodine atoms.
[0098] As to any of the groups described herein which contain one or more substituents, it is understood that such groups do not contain any substitution or substitution patterns which are sterically impractical and / or synthetically non-feasible. In addition, the disclosed compounds include all stereochemical isomers arising from the substitution of these compounds. Optional substitution of alkyl groups includes substitution with one or more alkenyl groups, aryl or heteroaryl groups, or both, wherein the alkenyl groups or aryl or heteroaryl groups are optionally substituted. Optional substitution of alkenyl groups includes substitution with one or more alkyl groups, aryl or heteroaryl groups, or both, wherein the alkyl groups or aryl or heteroaryl groups are optionally substituted. Optional substitution of aryl or heteroaryl groups includes substitution of the aryl or heteroaryl ring with one or more alkyl groups, alkenyl groups, or both,wherein the alkyl groups or alkenyl groups are optionally substituted.
[0099] Optional substituents for any alkyl, alkenyl, aryl, or heteroaryl group includes substitution with one or more of the following substituents, among others:
[0100] halogen, including fluorine, chlorine, bromine, or iodine;
[0101] pseudohalides, including –CN;
[0102] –COOR where R is a hydrogen or an alkyl group or an aryl or heteroaryl group or, more specifically, where R is a methyl, ethyl, propyl, butyl, or phenyl group, all of which are optionally substituted;
[0103] –COR where R is a hydrogen or an alkyl group or an aryl or heteroaryl group or, more specifically, where R is a methyl, ethyl, propyl, butyl, or phenyl group, all of which are optionally substituted;
[0104] –CON(R)2 where each R, independently of each other R, is a hydrogen or an alkyl group or an aryl or heteroaryl group or, more specifically, where R is a methyl, ethyl, propyl, butyl, or phenyl group, all of which are optionally substituted; and where R and R can optionally form a ring which can contain one or more double bonds and can contain one or more additional carbon atoms;
[0105] –OCON(R)2where each R, independently of each other R, is a hydrogen or an alkyl group or an aryl or heteroaryl group and, more specifically, where R is a methyl, ethyl, propyl, butyl, or phenyl group, all of which are optionally substituted; and where R and R can optionally form a ring which can contain one or more double bonds and can contain one or more additional carbon atoms;
[0106] –N(R)2 where each R, independently of each other R, is a hydrogen, or an alkyl group, or an acyl group or an aryl or heteroaryl group or, more specifically, where R is a methyl, ethyl, propyl, butyl, phenyl, or acetyl group, all of which are optionally substituted; and where R and R can optionally form a ring which can contain one or more double bonds and can contain one or more additional carbon atoms;
[0107] –SR, where R is hydrogen or an alkyl group or an aryl or heteroaryl group or, more specifically, where R is hydrogen, methyl, ethyl, propyl, butyl, or a phenyl group, all of whichare optionally substituted;
[0108] –SO2R, or –SOR where R is an alkyl group or an aryl or heteroaryl group or, more specifically, where R is a methyl, ethyl, propyl, butyl, or phenyl group, all of which are optionally substituted;
[0109] –OCOOR where R is an alkyl group or an aryl or heteroaryl group;
[0110] –SO2N(R)2where each R, independently of each other R, is a hydrogen, an alkyl group, or an aryl or heteroaryl group, all of which are optionally substituted, and wherein R and R can optionally form a ring which can contain one or more double bonds and can contain one or more additional carbon atoms;
[0111] –OR where R is H, an alkyl group, an aryl or heteroaryl group, or an acyl group, all of which are optionally substituted. In a particular example R can be an acyl, yielding –OCOR” where R” is a hydrogen or an alkyl group or an aryl or heteroaryl group and more specifically where R” is methyl, ethyl, propyl, butyl, or phenyl groups, all of which are optionally substituted.
[0112] Specific substituted alkyl groups include haloalkyl groups, particularly trihalomethyl groups and specifically trifluoromethyl groups. Specific substituted aryl groups include mono-, di-, tri, tetra- and penta-halo-substituted phenyl groups; mono-, di-, tri-, tetra-, penta-, hexa-, and hepta-halo-substituted naphthalene groups; 3- or 4-halo-substituted phenyl groups, 3- or 4-alkyl- substituted phenyl groups, 3- or 4-alkoxy-substituted phenyl groups, 3- or 4-RCO-substituted phenyl, 5- or 6-halo-substituted naphthalene groups. More specifically, substituted aryl groups include acetylphenyl groups, particularly 4-acetylphenyl groups; fluorophenyl groups, particularly 3-fluorophenyl and 4-fluorophenyl groups; chlorophenyl groups, particularly 3- chlorophenyl and 4-chlorophenyl groups; methylphenyl groups, particularly 4-methylphenyl groups; and methoxyphenyl groups, particularly 4-methoxyphenyl groups.
[0113] The term “electron acceptor” refers to a chemical composition that can accept an electron from another structure or compound. The term electron acceptor may be used, in some cases, in a relative sense to identify a characteristic of a compound or a subgroup thereof as having a stronger affinity for receiving an additional electron as compared to another compound or a subgroup. For example, an electron acceptor may be an organic semiconductor moleculewith a relatively higher affinity for receiving an additional electron or a relatively weaker affinity for giving up an electron as compared to another organic semiconductor molecule. In an organic photovoltaic cell, an electron acceptor may be a compound having an ability to receive electrons from an electron donor. An electron acceptor may be a photoactive compound that generates an electron-hole pair (exciton) upon photoabsorption of light and which can transfer generated holes to an electron donor. In some examples, the term electron acceptor may also be used interchangeably with the terms electron acceptor compound, acceptor compound, acceptor material, or simply an acceptor (e.g., see FIG.5). Electron acceptors may be used in conjunction with electron donors to form a donor-acceptor heterojunction in a photovoltaic cell.
[0114] The term “electron donor” refers to a chemical composition that can donate an electron to another structure or compound. The term electron donor may be used, in some cases, in a relative sense to identify a characteristic of a compound or a subgroup thereof as having a weaker affinity for receiving an additional electron as compared to another compound or a subgroup. For example, an electron donor may be an organic semiconductor molecule with a relatively weaker affinity for receiving an additional electron or a relatively higher affinity for giving up an electron as compared to another organic semiconductor molecule. In an organic photovoltaic cell, an electron donor may be a compound having an ability to transfer electrons to an electron acceptor. An electron donor may be a photoactive compound that generates an electron-hole pair (exciton) upon photoabsorption of light and which can transfer generated electrons to an electron acceptor. In some examples, the term electron donor may also be used interchangeably with the terms electron donor compound, donor compound, donor material, or simply a donor (e.g., see FIG.5). Electron donors may be used in conjunction with electron acceptors to form a donor-acceptor heterojunction in a photovoltaic cell.
[0115] An “electron acceptor moiety” refers to a moiety or subgroup of a photoactive compound that exhibits a relatively larger affinity for accepting electrons than other portions of the photoactive compound. An “electron donor moiety” refers to a moiety or subgroup of a photoactive compounds that exhibits a relatively larger affinity for donating electrons than other portions of the photoactive compound. Electron acceptor moieties, electron donor moieties, and (optionally) pi-bridging moieties may each comprise individual structural elements (e.g., a plurality of atoms in a covalent bonding arrangement) within a photoactive compound that maybe bonded to one another by way of one or more shared covalent bonds, optionally exhibiting conjugation between the electron donor moiety or moieties and the electron acceptor moiety or moieties.
[0116] A “π-bridging moiety” or a “pi-bridging moiety” refers to a moiety or subgroup of a photoactive compound. A π-bridging moiety or a pi-bridging moiety may provide extended conjugation of π- or, optionally, p-electrons and linking between different portions of the compound by way of a bivalent structure. Extended conjugation may occur when bonds in a chemical compound are in an alternating configuration of single-bonds and multiple-bonds (e.g., double- or triple-bonds). In some cases, extended conjugation may contribute additional electrons to an aromatic system.
[0117] As used herein, the terms visible transparency, visibly transparent, and the like refer to an optical property of a material that exhibits an overall absorption, average absorption, or maximum absorption in the visible band of 0%-70%, such as less than or about 70%, less than or about 65%, less than or about 60%, less than or about 55%, less than or about 50%, less than or about 45%, less than or about 40%, less than or about 35%, less than or about 30%, less than or about 25%, or less than or about 20%. Stated another way, visibly transparent materials may transmit 30%-100% of incident visible light, such as greater than or about 80% of incident visible light, greater than or about 75% of incident visible light, greater than or about 70% of incident visible light, greater than or about 65% of incident visible light, greater than or about 60% of incident visible light, greater than or about 55% of incident visible light, greater than or about 50% of incident visible light, greater than or about 45% of incident visible light, greater than or about 40% of incident visible light, greater than or about 35% of incident visible light, or greater than or about 30% of incident visible light. Visibly transparent materials are generally considered at least partially see-through (e.g., not completely opaque) when viewed by a human. Optionally, visibly transparent materials may be colorless (e.g., not exhibit strong visible absorption features that would provide an appearance of a particular color) when viewed by a human.
[0118] As used herein, the term “visible” refers to a band of electromagnetic radiation for which the human eye is sensitive. For example, visible light may refer to light having wavelengths between about 450 nm and about 650 nm.
[0119] The term “near-infrared” or “NIR” refers to a band of electromagnetic radiation having wavelengths longer than those for which the human eye is sensitive. For example, near-infrared light may refer to light having wavelengths greater than 650 nm, such as between about 650 nm and about 1400 nm or between about 650 nm and 2000 nm.
[0120] The term “ultraviolet” or “UV” refers to a band of electromagnetic radiation having wavelengths shorter than those for which the human eye is sensitive. For example, ultraviolet light may refer to light having wavelengths less than 450 nm, such as between about 200 nm and about 450 nm or between about 280 nm and 450 nm.
[0121] The disclosed compounds can be used in any application, though the specific application described herein is for use as photoactive compounds in an organic photovoltaic device, such as electron acceptor compounds or electron donor compounds. In some examples, the disclosed compounds are paired with a counterpart photoactive material (e.g., an electron donor material or an electron acceptor material) to form heterojunction structures comprising an electron donor compound and a counterpart electron acceptor material or comprising an electron acceptor compound and a counterpart electron donor material, as further described below, for use in generating and separating electron-hole pairs for converting electromagnetic radiation (e.g., ultraviolet light, visible light, and / or near-infrared light) into useful electrical energy (e.g., voltage / current). In a specific example, the photovoltaic device incorporating one or more of the disclosed photoactive compounds is a visibly transparent photovoltaic device. In other examples, the photovoltaic device incorporating one or more of the disclosed photoactive compounds is a partially transparent photovoltaic device, a colored partially transparent photovoltaic device, or an opaque photovoltaic device.
[0122] FIG.3A is a simplified schematic diagram illustrating a photovoltaic device according to some examples. As illustrated in FIG.3A, the photovoltaic device 300 includes a number of layers and elements discussed more fully below. As discussed in relation to FIG.4, the photovoltaic device 300 may be visibly transparent, which indicates that the photovoltaic device absorbs optical energy at wavelengths outside the visible wavelength band of 450 nm to 650 nm, for example, while substantially transmitting visible light inside the visible wavelength band. As illustrated in FIG.3A, UV and / or NIR light is absorbed in the layers and elements of the photovoltaic device while visible light is transmitted through the device, though in some cases,such as in a partially transparent photovoltaic device or an opaque photovoltaic device, visible light may be absorbed, such as by a photoactive layer.
[0123] Substrate 305, which can be glass or other visibly transparent materials providing sufficient mechanical support to the other layers and structures illustrated, supports optical layers 310 and 312. These optical layers can provide a variety of optical properties, including antireflection (AR) properties, wavelength selective reflection or distributed Bragg reflection properties, index matching properties, encapsulation, or the like. Optical layers may advantageously be visibly transparent. An additional optical layer 314 can be utilized, for example, as an AR coating, an index matching later, a passive infrared or ultraviolet absorption layer, etc. Optionally, optical layers may be transparent to ultraviolet and / or near-infrared light or transparent to at least a subset of wavelengths in the ultraviolet and / or near-infrared bands. Depending on the configuration, additional optical layer 314 may also be a passive visible absorption layer or a neutral filter, for example. Example substrate materials include various glasses and rigid or flexible polymers. Multilayer substrates may also be utilized. Substrates may have any suitable thickness to provide the mechanical support needed for the other layers and structures, such as, for example, thicknesses from 1 mm to 20 mm. In some cases, the substrate may be or comprise an adhesive film to allow application of the photovoltaic device 300 to another structure, such as a window pane, display device, etc.
[0124] It will be appreciated that, although some of devices described herein exhibit visible transparency, photovoltaic devices are also disclosed herein that are not fully visibly transparent, as some of the photoactive compounds described herein may exhibit visible absorption. In the case of a visibly transparent photovoltaic device that overall exhibits visible transparency, such as a transparency in the 450-650 nm range greater than 30%, greater than 40%, greater than 50%, greater than 60%, greater than 70%, or up to or approaching 100%, certain materials taken individually may exhibit absorption in portions of the visible spectrum. Optionally, each individual material or layer in a visibly transparent photovoltaic device has a high transparency in the visible range, such as greater than 30% (e.g., between 30% and 100%). It will be appreciated that transmission or absorption may be expressed as a percentage and may be dependent on the material’s absorbance properties, a thickness or path length through an absorbing material, and a concentration of the absorbing material, such that a material with anabsorbance in the visible spectral region may still exhibit a low absorption or high transmission if the path length through the absorbing material is short and / or the absorbing material is present in low concentration.
[0125] As described herein and below, various photoactive materials in various photoactive layers advantageously can exhibit minimal absorption in the visible region (e.g., less than 20%, less than 30%, less than 40%, less than 50%, less than 60%, or less than 70%), and instead exhibit high absorption in the near-infrared and / or ultraviolet regions (e.g., an absorption peak of greater than 50%, greater than 60%, greater than 70%, or greater than 80%). For some applications, absorption in the visible region may be as large as 70%. Various configurations of other materials, such as the substrate, optical layers, and buffer layers, may be useful for allowing these materials to provide overall visible transparency, even though the materials may exhibit some amount of visible absorption. For example, a thin film of a metal may be included in a transparent electrode, such as a metal that exhibits visible absorption, like Ag or Cu; when provided in a thin film configuration, however, the overall transparency of the film may be high. Similarly, materials included in an optical or buffer layer may exhibit absorption in the visible range but may be provided at a concentration or thickness where the overall amount of visible light absorption is low, providing visible transparency.
[0126] The photovoltaic device 300 also includes a set of transparent electrodes 320 and 322 with a photoactive layer 340 positioned between electrodes 320 and 322. These electrodes, which can be fabricated using ITO, thin metal films, or other suitable visibly transparent materials, provide electrical connection to one or more of the various layers illustrated. For example, thin films of copper, silver, or other metals may be suitable for use as a visibly transparent electrode, even though these metals may absorb light in the visible band. When provided as a thin film, however, such as a film having a thickness of 1 nm to 200 nm (e.g., about 5 nm, about 10 nm, about 15 nm, about 20 nm, about 25 nm, about 30 nm, about 35 nm, about 40 nm, about 45 nm, about 50 nm, about 55 nm, about 60 nm, about 65 nm, about 70 nm, about 75 nm, about 80 nm, about 85 nm, about 90 nm, about 95 nm, about 100 nm, about 105 nm, about 110 nm, about 115 nm, about 120 nm, about 125 nm, about 130 nm, about 135 nm, about 140 nm, about 145 nm, about 150 nm, about 155 nm, about 160 nm, about 165 nm, about 170 nm, about 175 nm, about 180 nm, about 185 nm, about 190 nm, or about 195 nm), an overalltransmittance of or through the thin film in or across (e.g., on average) the visible band may remain high, such as greater than 30%, greater than 40%, greater than 50%, greater than 60%, greater than 70%, greater than 80%, or greater than 90%. Advantageously, thin metal films, when used as transparent electrodes, may exhibit lower absorption in the ultraviolet band than other semiconducting materials that may be useful as a transparent electrode, such as ITO, as some semiconducting transparent conducting oxides exhibit a band gap that occurs in the ultraviolet band and thus are highly absorbing or opaque to ultraviolet light. In some cases, however, an ultraviolet absorbing transparent electrode may be used, such as to screen at least a portion of the ultraviolet light from underlying components, as ultraviolet light may degrade certain materials.
[0127] A variety of deposition techniques may be used to generate a transparent electrode, including vacuum deposition techniques, such as atomic layer deposition, chemical vapor deposition, physical vapor deposition, thermal evaporation, sputter deposition, epitaxy, etc. Solution based deposition techniques, such as spin-coating, may also be used in some cases. In addition, various components, such as transparent electrodes, may be patterned using techniques known in the art of microfabrication, including lithography, lift off, etching, etc.
[0128] Buffer layers 330 and 332 and photoactive layer 340 are utilized to implement the electrical and optical properties of the photovoltaic device. These layers can be layers of a single material or can include multiple sub-layers as appropriate to the particular application. Thus, the term “layer” is not intended to denote a single layer of a single material but can include multiple sub-layers of the same or different materials. In some cases, layers may partially or completely overlap. In some examples, buffer layer 330, photoactive layer(s) 340 and buffer layer 332 are repeated in a stacked configuration to provide tandem device configurations, such as including multiple heterojunctions. In some examples, the photoactive layer(s) include electron donor materials and electron acceptor materials, also referred to as donors and acceptors. These donors and acceptors can, in some cases, be visibly transparent, but absorb outside the visible wavelength band to provide the photoactive properties of the device. In the case of partially transparent and opaque photovoltaic devices, the donors and / or acceptors can absorb in the visible region.
[0129] Useful buffer layers include those that function as electron transport layers, electron blocking layers, hole transport layers, hole blocking layers, exciton blocking layers, optical spacers, physical buffer layers, charge recombination layers, or charge generation layers. Buffer layers may exhibit any suitable thickness to provide the buffering effect desired and may optionally be present or absent. Useful buffer layers, when present, may have thicknesses from 1 nm to 1 µm. Various materials may be used as buffer layers, including fullerene materials, carbon nanotube materials, graphene materials, metal oxides, such as molybdenum oxide, titanium oxide, zinc oxide, etc., polymers, such as poly(3,4-ethylenedioxythiophene), polystyrene sulfonic acid, polyaniline, etc., copolymers, polymer mixtures, and small molecules, such as bathocuproine. Buffer layers may be applied using a deposition process (e.g., thermal evaporation) or a solution processing method (e.g., spin coating).
[0130] FIG.3B depicts an overview of various example single junction configurations for photoactive layer 340. Photoactive layer 340 may optionally correspond to mixed donor / acceptor (bulk heterojunction) configurations, planar donor / acceptor configurations, planar and mixed donor / acceptor configurations, or gradient donor / acceptor configurations. Various materials may be used as the photoactive layers 340, such as visibly transparent materials that absorb in the ultraviolet band or the near-infrared band but that only absorb minimally, if at all, in the visible band. In this way, the photoactive material may be used to generate electron-hole pairs for powering an external circuit by way of ultraviolet and / or near- infrared absorption, leaving the visible light relatively unperturbed to provide visible transparency. In other cases, however, photoactive layers 340 may include materials that absorb in the visible region. As illustrated, photoactive layer 340 may comprise a planar heterojunction including separate donor and acceptor layers. Photoactive layer 340 may alternatively comprise a planar-mixed heterojunction structure including separate acceptor and donor layers and a mixed donor-acceptor layer. Photoactive layers 340 may alternatively comprise a mixed heterojunction structure including a fully mixed acceptor-donor layer or those including a mixed donor-acceptor layer with various relative concentration gradients.
[0131] Photoactive layers 340 may have any suitable thickness and may have any suitable concentration or composition of photoactive materials to provide a desired level of transparency and ultraviolet / near-infrared absorption characteristics. Example thicknesses of a photoactivelayer may range from about 1 nm to about 1 µm, about 1 nm to about 300 nm, or about 1 nm to about 100 nm. In some cases, photoactive layers 340 may be made up of individual sub-layers or mixtures of layers to provide suitable photovoltaic power generation characteristics, as illustrated in FIG.3B. The various configurations depicted in FIG.3B may be used and dependent on the particular donor and acceptor materials used in order to provide advantageous photovoltaic power generation. For example, some donor and acceptor combinations may benefit from particular configurations, while other donor and acceptor combinations may benefit from other particular configurations. Donor materials and acceptor materials may be provided in any ratio or concentration to provide suitable photovoltaic power generation characteristics. For mixed layers, the relative concentration of donors to acceptors is optionally between about 20 to 1 and about 1 to 20. Optionally, the relative concentration of donors to acceptors is optionally between about 5 to 1 and about 1 to 5. Optionally, donors and acceptors are present in a 1 to 1 ratio.
[0132] It will be appreciated that, in various examples, photovoltaic device 300 comprises transparent electrode 320, photoactive layer(s) 340, and transparent electrode 322, and that any one or more of substrate 305, optical layers 310, 312, and 314, and / or buffer layers 330 and 332 may be optionally included or excluded.
[0133] As described more fully herein, disclosed examples can employ photoactive compounds for one or more of the buffer layers, optical layers, and / or the photoactive layers. These compounds can include suitably functionalized versions for modification of the electrical and / or optical properties of the core structure. As an example, the disclosed compounds can include functional groups that decrease the absorption properties in the visible wavelength band between 450 nm to 650 nm and increase the absorption properties in the NIR band at wavelengths greater than 650 nm.
[0134] As an example, the disclosed photoactive compounds are useful as an electron acceptor materials or electron donor materials and may be paired with suitable counterpart materials of the opposite character, such as counterpart electron donor materials or counterpart electron acceptor materials, in order to provide a useful heterojunction-based photoactive layer in the photovoltaic device. Example electron donor photoactive materials or electron acceptor photoactive materialsmay be visibly transparent. In cases of partially transparent or opaque photovoltaic devices, the photoactive materials can absorb light in the visible region.
[0135] In examples, the chemical structure of the photoactive compounds can be functionalized with one or more directing groups, such as electron donating groups, electron withdrawing groups, or substitutions about or to a core metal atom or group, in order to provide desirable electrical characteristics to the material. In some examples, the photoactive compounds are functionalized with amine groups, phenol groups, alkyl groups, phenyl groups, or other electron donating groups to improve the ability of the material to function as an electron donor in a photovoltaic device. As another example, the photoactive compounds may optionally be functionalized with nitrile groups, halogens, sulfonyl groups, or other electron withdrawing groups to improve the ability of the material to function as an electron acceptor in a photovoltaic device.
[0136] In examples, the photoactive compounds are functionalized to provide desirable optical characteristics. For example, the photoactive compounds may optionally be functionalized with an extended conjugation to redshift the absorption profile of the material. It will be appreciated that conjugation may refer to a delocalization of pi electrons in a molecule and may be characterized by alternating single and multiple bonds in a molecular chemical structure, and / or the presence of aromatic structures. For example, functionalizations that extend the electron conjugation may include fusing one or more aromatic groups to the molecular structure of the material. Other functionalizations that may provide extended conjugation include alkene functionalization, such as by a vinyl group, aromatic or heteroaromatic functionalization, carbonyl functionalization, such as by an acyl group, sulfonyl functionalization, nitro functionalization, cyano functionalization, etc. It will be appreciated that various molecular functionalizations may impact both the optical and the electrical properties of the photoactive compounds.
[0137] It will be appreciated that device function may be impacted by the morphology of the active layers in the solid state. Separation of electron donors and acceptors into discrete domains, with dimensions on the scale of the exciton diffusion length and large interfacial areas, can be advantageous for achieving high device efficiency. Advantageously, the molecular framework of the photoactive materials can be tailored to control the morphology of thematerials. For example, the introduction of functional groups as described herein can have large impacts to the morphology of the material in the solid state, regardless of whether such modifications impact the energetics or electronic properties of the material. Such morphological variations can be observed in pure materials and when a particular material is blended with a corresponding donor or acceptor. Useful functionalities to control morphology include, but are not limited to, addition of alkyl chains, conjugated linkers, fluorinated alkanes, bulky groups (e.g., tert-butyl, phenyl, naphthyl or cyclohexyl), as well as more complex coupling procedures designed to force parts of the structure out of the plane of the molecule to inhibit excessive crystallization.
[0138] In examples, other molecular structural characteristics may provide desirable electrical and optical properties in the photoactive compounds. For example, the photoactive compounds may optionally exhibit portions of the molecule that may be characterized as electron donating while other portions of the molecule may be characterized as electron accepting. Without wishing to be bound by any theory, molecules including alternating electron donating and electron accepting portions may result in red-shifting the absorption characteristics of the molecule as compared to similar molecules lacking alternating electron donating and electron accepting portions. For example, alternating electron donating and electron accepting portions may decrease or otherwise result in a lower energy gap between a highest occupied molecular orbital and a lowest unoccupied molecular orbital. Organic donor and / or acceptor groups may be useful as R-group substituents, such as on any aryl, aromatic, heteroaryl, heteroaromatic, alkyl, or alkenyl group, in the visibly transparent photoactive compounds described herein. Example acceptor and donor groups are described below in more detail.
[0139] When the materials described herein are incorporated as a photoactive layer in a photovoltaic device, for example as an electron acceptor or an electron donor, the layer thicknesses can be controlled to vary device output, absorbance, or transmittance. For example, increasing the donor or acceptor layer thickness can increase the light absorption in that layer. In some cases, increasing the concentration of donor / acceptor materials in a donor or acceptor layer may similarly increase the light absorption in that layer. However, in some examples, a concentration of donor / acceptor materials may not be adjustable, such as when active material layers comprise pure or substantially pure layers of donor / acceptor materials or pure orsubstantially pure mixtures of donor / acceptor materials. Optionally, donor / acceptor materials may be provided in a solvent or suspended in a carrier, such as a buffer layer material, in which case the concentration of donor / acceptor materials may be adjusted. In some examples, the donor layer concentration is selected where the current produced is maximized. In some examples, the acceptor layer concentration is selected where the current produced is maximized.
[0140] However, the charge collection efficiency can decrease with increasing donor or acceptor thickness due to the increased “travel distance” for the charge carriers. Therefore, there may be a trade-off between increased absorption and decreasing charge collection efficiency with increasing layer thickness. It can thus be advantageous to select materials as described herein that have a high absorption coefficient and / or concentration to allow for increased light absorption per thickness. In some examples, the donor layer thickness is selected where the current produced is maximized. In some examples, the acceptor layer thickness is selected where the current produced is maximized.
[0141] In addition to the individual photoactive layer thicknesses formed from materials described herein, the thickness and composition of the other layers in the transparent photovoltaic device can also be selected to enhance absorption within the photoactive layers. The other layers (buffer layers, electrodes, etc.), are typically selected based on their optical properties (index of refraction and extinction coefficient) in the context of the thin film device stack and resulting optical cavity. For example, a near-infrared absorbing photoactive layer can be positioned in the peak of the optical field for the near-infrared wavelengths where it absorbs to maximize absorption and resulting current produced by the device. This can be accomplished by spacing the photoactive layer at an appropriate distance from the electrode using a second photoactive layer and / or optical layers as spacer. A similar scheme can be used for ultraviolet or visible absorbing photoactive layers. In many cases, the peaks of the longer wavelength optical fields will be positioned further from the more reflective of the two transparent electrodes compared to the peaks of the shorter wavelength optical fields. Thus, when using separate donor and acceptor photoactive layers, the donor and acceptor can be selected to position the more red- absorbing (longer wavelength) material further from the more reflective electrode and the more blue-absorbing (shorter wavelength) closer to the more reflective electrode.
[0142] In some examples, optical layers may be included to increase the intensity of the optical field at wavelengths where the donor absorbs in the donor layer to increase light absorption and hence, increase the current produced by the donor layer. In some examples, optical layers may be included to increase the intensity of the optical field at wavelengths where the acceptor absorbs in the acceptor layer to increase light absorption and hence, increase the current produced by the acceptor layer. In some examples, optical layers may be used to improve the transparency of the stack by either decreasing visible absorption or visible reflection. Further, the electrode material and thickness may be selected to enhance absorption outside the visible range within the photoactive layers, while preferentially transmitting light within the visible range.
[0143] Optionally, enhancing spectral coverage of a photovoltaic device is achieved by the use of a multi-cell series stack of photovoltaic devices, referred to as tandem cells, which may be included as multiple stacked instances of buffer layer 330, photoactive layer 340, and buffer layer 332, as described with reference to FIG.3A. This architecture includes more than one photoactive layer, which are typically separated by a combination of buffer layer(s) and / or thin metal layers, for example. In this architecture, the currents generated in each subcell flow in series to the opposing electrodes and therefore, the net current in the cell is limited by the smallest current generated by a particular subcell, for example. The open circuit voltage (VOC) is equal to the sum of the VOCs of the subcells. By combining sub-cells fabricated with different donor-acceptors pairs which absorb in different regions of the solar spectrum, a significant improvement in efficiency relative to a single junction cell can be achieved.
[0144] Additional description related to the materials utilized in one or more of the buffer layers and the photoactive layers, including donor layers and / or acceptor layers, are provided below.
[0145] FIG.4 is simplified plot illustrating the solar spectrum, human eye sensitivity, and exemplary visibly transparent photovoltaic device absorption as a function of wavelength. As illustrated in FIG.4, examples of visibly transparent photovoltaic devices utilize photovoltaic structures that have low absorption in the visible wavelength band between about 450 nm and about 650 nm, but absorb in the UV and NIR bands, e.g., outside the visible wavelength band, enabling visibly transparent photovoltaic operation. The ultraviolet band or ultraviolet regionmay be described, in examples, as wavelengths of light of between about 200 nm and 450 nm. It will be appreciated that useful solar radiation at ground level may have limited amounts of ultraviolet less than about 280 nm and, thus, the ultraviolet band or ultraviolet region may be described as wavelengths of light of between about 280 nm and 450 nm, in some examples. The near-infrared band or near-infrared region may be described, in examples, as wavelengths of light of between about 650 nm and 1400 nm. Various compositions described herein may exhibit absorption including a NIR peak with a maximum absorption strength in the visible region that is smaller than that in the NIR region.
[0146] FIG.5 provides a schematic energy level diagram overview for operation of an example organic photovoltaic device, such as visibly transparent photovoltaic device 300. For example, in such a photovoltaic device, various photoactive materials may exhibit electron donor or electron acceptor characteristics, depending on their properties and the types of materials that are used for buffer layers, counterpart materials, electrodes, etc. As depicted in FIG.5, each of the donor and acceptor materials have a highest occupied molecular orbital (HOMO) and a lowest unoccupied molecular orbital (LUMO). A transition of an electron from the HOMO to the LUMO may be imparted by absorption of photons. The energy between the HOMO and the LUMO (the HOMO-LUMO gap) of a material represents approximately the energy of the optical band gap of the material. For the electron donor and electron acceptor materials useful with the transparent photovoltaic devices provided herein, the HOMO-LUMO gap for the electron donor and electron acceptor materials preferably falls outside the energy of photons in the visible range. For example, the HOMO-LUMO gap may be in the ultraviolet region or the near-infrared region, depending on the photoactive materials. In some cases, the HOMO-LUMO gap may be in the visible region or overlap with the visible region and the ultraviolet region or overlap with the visible region and the near-infrared region, such as for partially transparent or opaque photovoltaic devices. It will be appreciated that the HOMO is comparable to the valence band in conventional conductors or semiconductors, while the LUMO is comparable to the conduction band in conventional conductors or semiconductors.
[0147] The narrow absorption spectrum of many organic molecules, such as organic semiconductors, can make it difficult to absorb the entire absorption spectra using a single molecular species. Therefore, electron donor and acceptor molecules are generally paired toafford a complementary absorption spectrum and increase spectral coverage of light absorption. Additionally, the donor and acceptor molecules are selected such that their energy levels (HOMO and LUMO) lie favorably with respect to one another. The difference in the LUMO level of donor and acceptor provides a driving force for dissociation of electron-hole pairs (excitons) created on the donor whereas the difference in the HOMO levels of donor and acceptors provides driving force for dissociation of electron-hole pairs (excitons) created on the acceptor. In some examples, it may be useful for the acceptor to have high electron mobility to efficiently transport electrons to an adjacent buffer layer. In some examples, it may be useful for the donor to have high hole mobility to efficiently transport holes to the buffer layer. Additionally, in some examples, it may be useful to increase the difference in the LUMO level of the acceptor and the HOMO level of the donor to increase the open circuit voltage (VOC), since VOC has been shown to be directly proportional to the difference between LUMO of the acceptor and HOMO of the donor. Such donor-acceptor pairings within the photoactive layer may be accomplished by appropriately pairing one of the materials described herein with a complementary material, which could be a different photoactive compound described herein or a completely separate material system.
[0148] The buffer layer adjacent to the donor, generally referred to as the anode buffer layer or hole transport layer, is selected such that HOMO level or valence band (in the case of inorganic materials) of the buffer layer is aligned in the energy landscape with the HOMO level of the donor to transport holes from the donor to the anode (transparent electrode). In some examples, it may be useful for the buffer layer to have high hole mobility. The buffer layer adjacent to the acceptor, generally referred to as the cathode buffer layer or electron transport layer, is selected such that LUMO level or conduction band (in the case of inorganic materials) of the buffer layer is aligned in the energy landscape with the LUMO level of the acceptor to transport electrons from the acceptor to the cathode (transparent electrode). In some examples, it may be useful for the buffer layer to have high electron mobility.
[0149] FIG.6A, FIG.6B, FIG.6C, and FIG.6D provide plots showing example absorption bands for different electron donor and electron acceptor configurations useful with visibly transparent photovoltaic devices. In FIG.6A, the donor material exhibits absorption in the NIR, while the acceptor material exhibits absorption in the UV. FIG.6B depicts the oppositeconfiguration, where the donor material exhibits absorption in the UV, while the acceptor material exhibits absorption in the NIR.
[0150] FIG.6C depicts an additional configuration, where both the donor and acceptor materials exhibit absorption in the NIR. As illustrated in the figures, the solar spectrum exhibits significant amounts of useful radiation in the NIR with only relatively minor amounts in the ultraviolet, making the configuration depicted in FIG.6C useful for capturing a large amount of energy from the solar spectrum. It will be appreciated that other examples include where both the donor and acceptor materials exhibit absorption in the NIR, such as depicted in FIG.6D where the acceptor is blue shifted relative to the donor, opposite the configuration depicted in FIG.6C, where the donor is blue shifted relative to the acceptor.
[0151] The present disclosure also provides methods for making photovoltaic devices, such as photovoltaic device 300. For example, FIG.7 provides an overview of an example method 700 for making a photovoltaic device. Method 700 begins at block 705, where a transparent substrate is provided. It will be appreciated that useful transparent substrates include visibly transparent substrates, such as glass, plastic, quartz, and the like. Flexible and rigid substrates are useful with various examples. Optionally, the transparent substrate is provided with one or more optical layers preformed on top and / or bottom surfaces.
[0152] At block 710, one or more optical layers are optionally formed on or over the transparent substrate, such as on top and / or bottom surfaces of the transparent substrate. Optionally, the one or more optical layers are formed on other materials, such as an intervening layer or material, such as a transparent conductor. Optionally, the one or more optical layers are positioned adjacent to and / or in contact with the visibly transparent substrate. It will be appreciated that formation of optical layers is optional, and some examples may not include optical layers adjacent to and / or in contact with the transparent substrate. Optical layers may be formed using a variety of methods including, but not limited to, one or more chemical deposition methods, such as plating, chemical solution deposition, spin coating, dip coating, chemical vapor deposition, plasma enhanced chemical vapor deposition, and atomic layer deposition, or one or more physical deposition methods, such as thermal evaporation, electron beam evaporation, molecular beam epitaxy, sputtering, pulsed laser deposition, ion beam deposition, and electrospray deposition. It will be appreciated that useful optical layers include visiblytransparent optical layers. Useful optical layers include those that provide one or more optical properties including, for example, antireflection properties, wavelength selective reflection or distributed Bragg reflection properties, index matching properties, encapsulation, or the like. Useful optical layers may optionally include optical layers that are transparent to ultraviolet and / or near-infrared light. Depending on the configuration, however, some optical layers may optionally provide passive infrared and / or ultraviolet absorption. Optionally, an optical layer may include a visibly transparent photoactive compound described herein.
[0153] At block 715, a transparent electrode is formed. As described above, the transparent electrode may correspond to an indium tin oxide thin film or other transparent conducting film, such as thin metal films (e.g., Ag, Cu, etc.), multilayer stacks comprising thin metal films (e.g., Ag, Cu, etc.) and dielectric materials, or conductive organic materials (e.g., conducting polymers, etc.). It will be appreciated that transparent electrodes include visibly transparent electrodes. Transparent electrodes may be formed using one or more deposition processes, including vacuum deposition techniques, such as atomic layer deposition, chemical vapor deposition, physical vapor deposition, thermal evaporation, sputter deposition, epitaxy, etc. Solution based deposition techniques, such as spin-coating, may also be used in some cases. In addition, transparent electrodes may be patterned by way of microfabrication techniques, such as lithography, lift off, etching, etc.
[0154] At block 720, one or more buffer layers are optionally formed, such as on the transparent electrode. Buffer layers may be formed using a variety of methods including, but not limited to, one or more chemical deposition methods, such as a plating, chemical solution deposition, spin coating, dip coating, chemical vapor deposition, plasma enhanced chemical vapor deposition, and atomic layer deposition, or one or more physical deposition methods, such as thermal evaporation, electron beam evaporation, molecular beam epitaxy, sputtering, pulsed laser deposition, ion beam deposition, and electrospray deposition. It will be appreciated that useful buffer layers include visibly transparent buffer layers. Useful buffer layers include those that function as electron transport layers, electron blocking layers, hole transport layers, hole blocking layers, optical spacers, physical buffer layers, charge recombination layers, or charge generation layers. In some cases, the disclosed visibly transparent photoactive compounds maybe useful as a buffer layer material. For example, a buffer layer may optionally include a visibly transparent photoactive compound described herein.
[0155] At block 725, one or more photoactive layers are formed, such as on a buffer layer or on a transparent electrode. As described above, photoactive layers may comprise electron acceptor layers and electron donor layers or co-deposited layers of electron donors and acceptors. Useful photoactive layers include those comprising the photoactive compounds described herein. Photoactive layers may be formed using a variety of methods including, but not limited to, one or more chemical deposition methods, such as a plating, chemical solution deposition, spin coating, dip coating, chemical vapor deposition, plasma enhanced chemical vapor deposition, and atomic layer deposition, or one or more physical deposition methods, such as thermal evaporation, electron beam evaporation, molecular beam epitaxy, sputtering, pulsed laser deposition, ion beam deposition, and electrospray deposition.
[0156] In some examples, photoactive compounds useful for photoactive layers may be deposited using a vacuum deposition technique, such as thermal evaporation. Vacuum deposition may take place in a vacuum chamber, such as at pressures of between about 10-5Torr and about 10-8Torr. In one example, vacuum deposition may take place at a pressure of about 10-7Torr. As noted above, various deposition techniques may be applied. In some examples, thermal evaporation is used. Thermal evaporation may include heating a source of the material (e.g., the visibly transparent photoactive compound) to be deposited to a temperature of between 150 °C and 500 °C. The temperature of the source of material may be selected so as to achieve a thin film growth rate of between about 0.01 nm / s and about 1 nm / s. For example, a thin film growth rate of 0.1 nm / s may be used. These growth rates are useful to generate thin films having thicknesses of between about 1 nm and 500 nm over the course of minutes to hours. It will be appreciated that various properties (e.g., the molecular weight, volatility, thermal stability) of the material being deposited may dictate or influence the source temperature or maximum useful source temperature. For example, a thermal decomposition temperature of the material being deposited may limit the maximum temperature of the source. As another example, a material being deposited that is highly volatile may require a lower source temperature to achieve a target deposition rate as compared to a material that is less volatile, where a higher source temperature may be needed to achieve the target deposition rate. As the material being deposited isevaporated from the source, it may be deposited on a surface (e.g., substrate, optical layer, transparent electrode, buffer layer, etc.) at a lower temperature. For example the surface may have a temperature from about 10 °C to about 100 °C. In some cases, the temperature of the surface may be actively controlled. In some cases, the temperature of the surface may not be actively controlled.
[0157] At block 730, one or more buffer layers are optionally formed, such as on the photoactive layer. The buffer layers formed at block 730 may be formed similar to those formed at block 720. It will be appreciated that blocks 720, 725, and 730 may be repeated one or more times, such as to form a multilayer stack of materials including a photoactive layer and, optionally, various buffer layers.
[0158] At block 735, a second transparent electrode is formed, such as on a buffer layer or on a photoactive layer. Second transparent electrode may be formed using techniques applicable to formation of first transparent electrode at block 715.
[0159] At block 740, one or more additional optical layers are optionally formed, such as on the second transparent electrode.
[0160] It should be appreciated that the specific steps illustrated in FIG.7 provide a particular method of making a photovoltaic device according to various examples. Other sequences of steps may also be performed according to alternative examples. For example, alternative examples may perform the steps outlined above in a different order. Moreover, the individual steps illustrated in FIG.7 may include multiple sub-steps that may be performed in various sequences as appropriate to the individual step. Furthermore, additional steps may be added or removed depending on the particular applications. It will be appreciated that many variations, modifications, and alternatives may be used.
[0161] Method 700 may optionally be extended to correspond to a method for generating electrical energy. For example, a method for generating electrical energy may comprise providing a photovoltaic device, such as by making a photovoltaic device according to method 700. Methods for generating electrical energy may further comprise exposing the photovoltaic device to visible, ultraviolet and / or near-infrared light to drive the formation and separation of electron-hole pairs, as described above with reference to FIG.5, for example, for generation ofelectrical energy. The photovoltaic device may include the photoactive compounds described herein as photoactive materials, buffer materials, and / or optical layers.
[0162] Turning now to further details on photoactive compounds, in some examples, the photoactive compounds described herein comprises a molecular composition having or represented by a structure or formula D–A1–A2, D–pi–A1–A2, or D–A1–pi–A2, or D–pi–A1–pi– A2, where A1and A2are electron acceptor moieties, D is an electron donor moiety, and pi is a π- bridging moiety. It will be appreciated that the photoactive compounds may be considered small molecules in that they are not polymeric molecules (e.g., containing a series of repeating monomer units). Specific photoactive compounds disclosed herein include those where A2re each Y1is independently C(CN)2, O, S, or atic, heteroaromatic, fused-ring aromatic, or fused-ringheteroaromatic group having one or more substituents R, and each R may be H, F, Cl, Br, I, CH3, CF3, CF2H, CFH2, CCl3, or CN. For example, A2may be or comprise a substituted or unsubstituted indandione, a substituted or unsubstituted indandithione, a substituted or unsubstituted dicyanomethyleneindanone, or a substituted or unsubstituted bis(dicyanomethylidene)indan.
[0163] The disclosed photoactive compounds can exhibit optical properties, as described above, such as where the photoactive compound exhibits absorption in the ultraviolet, visible, and / or infrared regions. In some cases, the compounds exhibit a bandgap of from 0.5 eV to 4.0 eV, or from 0.5 to 3.0 eV, or from 0.5 to 2.5 eV, such as from 0.5 eV to 0.75 eV, from 0.75 eV, to 1.0 eV, from 1.0 eV to 1.25 eV, from 1.25 eV to 1.5 eV, from 1.5 eV to 1.75 eV, from 1.75 eV to 2.0 eV, from 2.0 eV to 2.25 eV, from 2.25 eV to 2.5 eV, from 2.5 eV to 2.75 eV, from 2.75 eV to 3.0 eV, from 3.0 eV to 3.25 eV, from 3.25 eV to 3.5 eV, from 3.5 eV to 3.75 eV or from 3.75 eV to 4.0 eV. For visibly transparent photoactive compounds, the bandgap may be from 0.5 eV to 1.9 eV or from 2.7 eV to 4.0 eV. Advantageously, the photoactive compounds can have molecular weights making them suitable for gas-phase deposition techniques. Example molecular weights may be from 250 amu to 1200 amu or from 250 amu to 900 amu, such as from 250 amu to 300 amu, from 300 amu to 350 amu, from 350 amu to 400 amu, from 400 amuty 450 amu, from 450 amu to 500 amu, from 500 amu to 550 amu, from 550 amu to 600 amu, from 600 amu to 650 amu, from 650 amu to 700 amu, from 700 amu to 750 amu, from 750 amu to 800 amu, from 800 amu to 850 amu, from 850 amu to 900 amu, from 900 amu to 950 amu, from 950 amu to 1000 amu, from 1000 amu to 1050 amu, from 1050 amu to 1100 amu, from 1100 amu to 1150 amu, or from 1150 amu to 1200 amu. Without limitation, the photoactive compounds described herein may be characterized by or exhibit a vapor pressure between 10-6Torr and 1 Torr at temperatures from 150 °C to 400 °C. In photovoltaic devices where the photoactive compounds are used in photoactive layers, the photoactive layers may comprise evaporation deposited layers or layers that are not deposited using solution processing. Advantageously, various of the disclosed photoactive compounds may be highly stable, such as exhibiting or characterized by a decomposition rate that is lower than an evaporation or sublimation rate at a particular temperature, such as temperatures used for vapor deposition (e.g., from about 150 °C to about 400 °C).
[0164] Each of the various D, A1, A2, and pi moieties in the photoactive compounds can impact the absorption profile, the volatility, the molecular stability, or the like. In some examples, the D and A2moieties may be a monovalent radical group, containing one unspecified covalent bond, such as to a pi moiety or the A1moiety. In some examples, the pi moieties may be bivalent radical groups, containing two unspecified covalent bonds, such as to the D moiety and the A1moiety or to the A2moiety and the A1moiety. In some examples, the A1moiety may be a bivalent radical group, containing two unspecified covalent bonds, such as to the D moiety and the A2moiety, or to the D moiety and a pi moiety, or to a pi moiety and the A2moiety.
[0165] In some examples, one or multiple bonds may link the D moiety, the pi moieties (if present), the A1moiety, and the A2moiety. In some examples, the D moiety may be bonded to the A1moiety or a pi moiety by a covalent bond, such as a single covalent bond. In some examples, a pi moiety may be bonded to the D moiety by a first covalent bond, such as a first single covalent bond, and may also be bonded to the A1moiety by a second covalent bond, such as a second single covalent bond. In some examples, a pi moiety may be bonded to the A1moiety by a first covalent bond, such as a first single covalent bond, and may also be bonded to the A2moiety by a second covalent bond, such as a second single covalent bond. In some examples, the A2moiety may be bonded to the A1moiety or a pi moiety by a covalent bond,yuch as a single covalent bond. In some examples, the D moiety and the A1moiety may comprise a fused moiety with electron donor and electron acceptor components. In some examples, the D moiety, a pi moiety, and the A1moiety may comprise a fused moiety with electron donor, pi-bridging, and electron acceptor components. Such fused D-A1or D-pi-A1moieties may be a monovalent radical group, containing one unspecified bond to another pi moiety or the A2moiety. In some examples, the D moiety may be linked to a pi moiety or the A1moiety by multiple separate covalent bonds. In some examples, the pi moiety may be linked to the D moiety and / or the A1moiety by multiple separate covalent bonds. In some examples, the A1moiety may be linked to a pi moiety or the D moiety by multiple separate covalent bonds. In some examples, a position indicated by a H group (H atom) in the various D, pi, or A1moieties described herein may represent a position for a second covalent bond between D and pi moieties, between D and A1moieties, or between pi and A1moieties.
[0166] In some examples, the D moiety in the disclosed photoactive compounds comprises a substituted or unsubstituted diarylamine, aromatic, heteroaromatic, polycyclic aromatic, or polycyclic heteroaromatic moiety, such as including one or more 5-membered rings, one or more 6-membered rings, or a combination of one or more 5-membered rings and one or more 6- membered rings. Example D moieties include, but are not limited to, , , ,, , , or . In examples each R may independently be H, F, Cl, Br, I, CH3, CF3, CF2H, CFH2, CCl3, OCH3, CN, or an aromatic or heterocyclic ring substituted with one or more H, F, CH3, CF3, CF2H, CFH2, CCl3, CN or a branched or straight chain alkyl group or fluoroalkyl group having a molecular weight of from 15 amu to 150 amu (e.g., 15 amu to 25 amu, 25 to 50 amu, 50 amu to 75 amu, 75 amu to 100 amu, 100 amu to 125 amu, or 125 amu to 150 amu). In examples, each X may independently be O, S, Se, NH, NRN, CH2, C(RN)2, Si(RN)2, or Ge(RN)2. In examples, each Ar may independently be a fused or unfused aromatic or heteroaromatic group including one or more R group substituents. In examples, ring B is a cycloalkyl or cycloalkenyl group having from 5 to 9 carbon atoms and including one or more R group substituents. In examples, RNmay be a branched, cyclic, or straight chain alkyl group or fluoroalkyl group having a molecular weight of from 15 amu to 150 amu (e.g., 15 amu to 25 amu, 25 to 50 amu, 50 amu to 75 amu, 75 amu to 100 amu, 100 amu to 125 amu, or 125 amu to 150 amu). In examples, each Y3may independently be CH, N, CR or CRN. In examples, R1may be an aromatic or heterocyclic ring substituted with H, F, CH3, CF3, CF2H, CFH2, CCl3, CN, or a branched or straight chain alkyl group or fluoroalkyl group having a molecular weight of from 15 amu to 150 amu (e.g., 15 amu to 25 amu, 25 to 50 amu, 50 amu to 75 amu, 75 amu to 100 amu, 100 amu to 125 amu, or 125 amu to 150 amu).
[0167] Specific example D moieties include those comprising or having a formula ,, , , , , or .
[0168] In some examples, the A1moiety in the disclosed photoactive compounds comprises a fused aromatic or heteroaromatic moiety, such as including 5-membered rings and / or one or more 6-membered rings, which may be substituted or unsubstituted. Example A1moieties include, but are not limited to, , , , , , , , , , or . Optionally, each R may be independently H, F, Cl, Br, I, CH3, CF3, CF2H, CFH2, CCl3, OCH3 or CN. In examples, each X1may independently be O, S, Se, C=O, or NRO. In examples, ROmay be H or a branched or straight chain alkyl group or fluoroalkyl group having a molecular weight of from 15 amu to 150 amu (e.g., 15 amu to 25 amu, 25 to 50 amu, 50 amu to 75 amu, 75 amu to 100 amu, 100 amu to 125 amu, or 125 amu to 150 amu).
[0169] Specific example A1moieties include those comprising or having a formula, , , , , , , , , , , or .
[0170] In some examples, a pi moiety in the disclosed photoactive compounds may be a bivalent radical moiety containing a series of conjugated bonds, providing extended conjugation between adjacent D, A1, and / or A2moieties. Examples of pi moieties useful with the disclosed photoactive compounds include, but are not limited to, , , , , , , , , , , , , , , , , , , , , , , , , , or . In examples, each X1may independently be O, S, Se, C=O, or NRN. In examples, each R may independently be H, F, Cl, Br, I, CH3, OCH3, CF3, CF2H, CFH2, CCl3, or CN. In examples, each X2may independently be O, S, Se, NH, NRN, CH2, or C(RN)2. In examples, each W may independently be H, F, or a branched or straight chain C1-C8 alkyl group or a branched orstraight chain C1-C8 alkoxy group. In examples, each RNmay independently be a branched, cyclic, or straight chain alkyl or fluorinated alkyl or ester group having a molecular weight of from 15 amu to 150 amu (e.g., 15 amu to 25 amu, 25 to 50 amu, 50 amu to 75 amu, 75 amu to 100 amu, 100 amu to 125 amu, or 125 amu to 150 amu).
[0171] Example substitutions for H in the A1, A2, D and pi moieties described herein may include, but are not limited to, F, Cl, Br, I, CH3, CF3, CF2H, CFH2, CCl3, CN, an aromatic or fused aromatic group, an aromatic or fused heteroaromatic group, a branched, cyclic, or straight chain alkyl or fluorinated alkyl group having a molecular weight of from 15 amu to 150 amu (e.g., 15 amu to 25 amu, 25 to 50 amu, 50 amu to 75 amu, 75 amu to 100 amu, 100 amu to 125 amu, or 125 amu to 150 amu), or a branched, cyclic, or straight chain alkenyl or fluorinated alkenyl group having a molecular weight of from 15 amu to 150 amu (e.g., 15 amu to 25 amu, 25 to 50 amu, 50 amu to 75 amu, 75 amu to 100 amu, 100 amu to 125 amu, or 125 amu to 150 amu). Other substitutions for H in the A1, A2, D and pi moieties are described elsewhere herein.
[0172] As noted above, A2in the disclosed compounds may comprise or . In examples, each Y1is independently C(CN)2, O, S, or cyanoimine. In examples, Y2is CH or N. In examples, Ar is an aromatic, heteroaromatic, fused-ring aromatic, or fused- ring heteroaromatic group having one or more substituents R, and each R may be H, F, Cl, Br, I, CH3, CF3, CF2H, CFH2, CCl3, or CN. Optionally, Ar comprises a substituted or unsubstituted heterocycle. Optionally, Ar comprises one or more five-membered or six-membered aromatic rings having one or more substituents R.
[0173] In examples, A2may be a substituted or unsubstituted indandione, a substituted or unsubstituted indandithione, a substituted or unsubstituted dicyanomethyleneindanone, or a substituted or unsubstituted bis(dicyanomethylidene)indan. In examples, each Y1is independently C(CN)2, O, S, or cyanoimine. In examples, Y2is CH or N.
[0174] Examples of the A2moiety may comprise or have the formu ,,. Optionally, the A2moiety may be an aryl-substituted indandione, an aryl-ndithione, an aryl-substituted dicyanomethyleneindanone, or an aryl-substituted bis(dicyanomethylidene)indan, which may optionally have further additional non-hydrogen substituents, such as on any aryl groups. An aryl-substituted indandione, an aryl-substituted indandithione, an aryl-substituted dicyanomethyleneindanone, or an aryl-substituted bis(dicyanomethylidene)indan may comprise or correspond to heteroaryl-substituted variants, such as a heteroaryl-substituted indandione, a heteroaryl-substituted indandithione, a heteroaryl- substituted dicyanomethyleneindanone, or a heteroaryl-substituted bis(dicyanomethylidene)indan.
[0175] Optionally, the A2moiety may be a fused-aryl indandione, a fused-aryl indandithione, a fused-aryl dicyanomethyleneindanone, or a fused-aryl bis(dicyanomethylidene)indan, which may optionally have further additional non-hydrogen substituents, such as on any aryl groups. A fused-aryl indandione, a fused-aryl indandithione, a fused-aryl dicyanomethyleneindanone, or a fused-aryl bis(dicyanomethylidene)indan may comprise or correspond to fused-heteroaryl variants, such as a fused-heteroaryl indandione, a fused-heteroaryl indandithione, a fused- heteroaryl dicyanomethyleneindanone, or a fused-heteroaryl bis(dicyanomethylidene)indan.Examples of the A2moiety may comprise or have the formula , , , , , , , , , , , , , , , , , or .
[0176] Specific example A2moieties include those comprising or having a formula ,, , , or
[0177] Some example photoactive compounds include those having a formula of:
[0178] Optionally, the D moiety may be fused together with the A1moiety. Optionally, the D moiety, a pi moiety, and the A1moiety may be fused together. In some examples, the D moiety and the pi moiety may together comprise a fused ring moiety. In some examples, the D moiety, the pi moiety, and the A1moiety may together comprise a fused ring moiety. In some examples, a D moiety that is fused to another moiety (e.g., a pi moiety or an A1moiety) comprises or has a formula , , , , , , , , , or . In some examples, a pi moiety that is fused to another moiety (e.g., a D moiety or an A1moiety) comprises or has a formula , , , , , , , , , or . In some examples, an A1moiety that is fused to another moiety (e.g., a D moiety or a pi moiety) comprises or has a formula , ,, , or . In some examples, the D moiety fused with the A1moiety or the D moiety, pi moiety, and A1moiety fused together comprises or has a formula: , , , , , or . In examples where A2is a fluorine substituted indandione, compounds where D, pi, and A1moieties are fused together include those having a formula , , , , 59, or . It will be appreciated that a variety of other photoactive compounds comprising various combinations of the disclosed D, pi, A1, and A2moieties are also included in this disclosure.
[0179] The disclosed photoactive compounds can be paired with a variety of other compounds to form a photovoltaic heterojunction. For example, when the photoactive compound is an electron acceptor compound, it can be paired with a counterpart electron donor material. As another example, when the photoactive compound is an electron donor compound, it can be paired with a counterpart electron acceptor material. A counterpart electron donor material may be a counterpart electron donor compound, for example, and may be different in some cases from the photoactive materials described herein. A counterpart electron acceptor material may be a counterpart electron donor compound, for example, and may be different in some cases from the photoactive materials described herein. In some cases, a photoactive layer may comprise one or multiple different electron donor compounds (e.g., blends of different photoactive compounds). In some cases, a photoactive layer may comprise one or multiple different electron acceptor compounds (e.g., blends of different photoactive compounds).
[0180] The photoactive compounds described herein can be paired with any of a variety of counterpart photoactive compounds. In some examples, the photoactive material of a device may contain a photoactive compound that is an electron acceptor compound described herein and the electron donor compound comprises a boron-dipyrromethene (BODIPY) compound, a metal- dipyrromethene coordinate compound, a phthalocyanine compound, a naphthalocyanine compound, a metal dithiolate (MDT) compound, a dithiophene squarine compound, an indacenodithieno[3,2-b]thiophene (ITIC) compound, or a core disrupted indacenodithieno[3,2- b]thiophene (ITIC) compound. Combinations thereof may also be used. Examples of useful BODIPY compounds include, but are not limited to, those described in U.S. Patent Application No.16 / 010,371, filed on June 15, 2018, which is hereby incorporated by reference. Examples of useful metal-dipyrromethene coordinate compounds include, but are not limited to, thosedescribed in U.S. Provisional Application No 63 / 140,733, filed on January 22, 2021, hereby incorporated by reference. Additional useful metal-dipyrromethene coordinate compounds include, but are not limited to, those described in U.S. Patent application 17 / 581,689, filed on August 4, 2022, which is hereby incorporated by reference. Examples of useful phthalocyanine and naphthalocyanine compounds include, but are not limited to, those described in U.S. Patent Application No.16 / 010,365, filed on June 15, 2018, which is hereby incorporated by reference. Examples of useful MDT compounds include, but are not limited to, those described in U.S. Patent Application No.16 / 010,369, filed on June 15, 2018, which is hereby incorporated by reference. Examples of useful dithiophene squarine compounds include, but are not limited to, those described in U.S. Patent Application No.16 / 010,374, filed on June 15, 2018, which is hereby incorporated by reference. Examples of useful core disrupted and / or planar ITIC compounds containing indandione groups include, but are not limited to, those described in PCT Application Application No. PCT / US2021 / 058125, filed on November 4, 2021, which is hereby incorporated by reference. In some examples, a photoactive layer contains a BODIPY compound, a phthalocyanine compound, a naphthalocyanine compound, a MDT compound, a dithiophene squarine compound, an ITIC compound, a core-disrupted ITIC compound, or a combination thereof.
[0181] Aspects of the invention may be further understood by reference to the following non- limiting examples. EXAMPLE 1 – SYNTHESIS OF EXAMPLE DONOR-ACCEPTOR-ACCEPTOR COMPOUNDS
[0182] FIGS.8-16 provide an overview of various example synthetic schemes providing synthetic routes for various compounds, including a number of donor-acceptor-acceptor compounds.
[0183] FIG.8 provides a synthetic scheme for preparation of the following example donor- acceptor-acceptor compounds:, , and .
[0184] Compound III: Compound II (5 g, 1.1 equiv) and compound I (1.0 equiv) were added to a 3-neck flask and dissolved in THF (50 vol). To this solution was added a 2 M solution of potassium carbonate (25 vol), the reaction mixture was then bubbled with nitrogen for 30 minutes. Pd(PPh3)4(0.1 g) was added and the reaction mixture was heated to 75 °C. The reaction mixture was cooled to room temperature and diluted with ethyl acetate, resulting in formation of a red precipitate. The precipitate was filtered then recrystallized in ethyl acetate / heptane to afford compound III as a red solid (5.4 g, 79% yield).
[0185] Compound V: Compound III (5.6 g, 1 equiv, 2.98 mmol) and compound IV (1.6 equiv) were combined in a 3-neck flask. THF (70 vol) was added and the mixture was degassed. Piperidine (0.2 vol) was added dropwise and the reaction was stirred at room temperature for 16 hours. The reaction mixture was concentrated then dry-loaded onto silica gel and purified by column chromatography. The product was eluted with Heptane:DCM. The resulting solid was then triturated with methanol, filtered, and dried to compound V (5.56 g, 72% yield). Compount V was sublimed in 85% yield.
[0186] Compound VII: Compound I (1 g, 1 equiv, 4 mmol), Compound VI (3 g, 1.15 equiv, 5 mmol), and Pd(PPh3)2Cl2 (0.03 g, 0.1 equiv, 0.04 mmol) were combined in a 100 mL 3-neck flask followed by 30 mL of toluene. The flask was purged with nitrogen then the reaction mixture was stirred at 110 °C for 2 hours. The reaction mixture was cooled to room temperaturethen evaporated and dry-loaded onto silica gel for purification. The product was eluted with Heptane:DCM to afford Compound VII as a dark purple solid (0.947 g, 50% yield).
[0187] Compound VIII: Compound VII (0.95 g, 1 equiv, 2.2 mmol) and compound IV (0.84 g, 2.2 equiv, 4.6 mmol) were combined in a 250 mL 3-neck flask. 74 mL of THF was added and the mixture was degassed then heated to 40 °C. Piperidine (76 μL, 0.35 equiv, 0.77 mmol) was added dropwise and the reaction mixture was stirred at 40 °C until complete. The reaction mixture was then cooled to room temperature and concentrated. The crude mixture was dry loaded onto silica gel and purified by column chromatography. Compound VIII was eluted with Heptane:DCM as dark blue solid (0.947 g, 73% yield). Compound VIII was sublimed with 2% yield.
[0188] Compound X: A solution of compound IX (18.20 g, 39.4 mmol, 1.00 equiv) and compound I (9.57 g, 39.4 mmol, 1.00 equiv) in toluene (910 mL, 50 vol) was degassed with nitrogen three times with stirring. Pd(PPh3)2Cl2(1.93 g, 2.76 mmol, 0.07 equiv) was charged and the yellow mixture was heated at reflux for 18 hours. Upon completion of reaction, the mixture was cooled and concentrated to a residue. The residue was washed with heptane (3.64 L, 200 vol). The remaining solids were dissolved in a minimal amount of DCM, which was filtered through a pad of silica to remove impurities. The silica was washed with dichloromethane until full elution of compound X without the baseline impurity. Compound X was isolated as a purple solid (5.05 g, 38% yield).
[0189] Compound XI: A solution of Compound X (4.75 g, 14.16 mmol, 1.0 equiv) and compound IV (4.38 g, 24.07 mmol, 1.7 equiv) in DCE (333 mL, 70 vol) was purged with nitrogen for 5 minutes. Triethylamine (a few drops, catalytic) was charged. The solution was stirred at room temperature until reaction completion. The reaction mixture was concentrated, and methanol (100 mL, 21 vol) was charged. The insoluble solids were filtered, and then further washed with methanol until the filtrate ran colorless. Compound XI was isolated as a dark solid (5.9 g, 83% yield). Compound XI did not sublime.
[0190] FIG.9 provides a synthetic scheme for preparation of the following compound: .II: Compound XII (10 g, 40.59 mmol, 1 equiv) was dissolved in THF (200 mL, 20 vol) to give a clear pale-yellow solution. The mixture was cooled to -78 °C. n-Butyllithium (25.9 mL, 64.75 mmol, 2.5 M, 1.6 equiv) was added dropwise, after which the mixture was cloudy white. Tributyltin chloride (16 mL, 58.86 mmol, 1.45 equiv) was added dropwise then the mixture was allowed to warm to room temperature and stirred for 18 hours. The clear orange mixture was cooled to 0 °C, quenched with water (200 mL), extracted with DCM (2 x 200 mL), dried with sodium sulfate and the solvent was removed to give compound XIII as a light brown oil (25.9 g, 119%). Material was used without further purification.
[0192] Compound XIV: Compound XIII (10 g, 1 equiv) and 4-bromotoluene (3.19 g, 18.676 mmol, 1.0 equiv) were dissolved in toluene (100 mL, 10 vol) to give a clear, light brown solution. Nitrogen was bubbled through the solution for 10 minutes before Pd2(dba)3 (1.23 g, 1.34 mmol, 0.072 equiv) and P(tBu)3 (3 mL, 2.988 mmol, 0.16 equiv) were added, turning the solution black. Nitrogen was bubbled through the mixture for another 10 minutes then the reaction mixture was heated to reflux. After 4-bromotoluene was consumed, the reaction mixture was cooled to room temperature, filtered and the solvent removed to give the crude product as a brown oil. The crude product was purified by column chromatography (100% heptane) to give compound XIV as a yellow-brown solid (3.3065 g, 75% yield).
[0193] Compound XV: Compound XIV (3.3 g, 9.8 mmol, 1 equiv) was dissolved in THF (66 mL, 20 vol) to give a light brown solution. The mixture was cooled to -78 °C. n-Butyllithium (5.3 mL, 13.24 mmol, 2.5 M, 1.35 equiv) was added dropwise. Tributyltin chloride (4.5 mL, 16.46 mmol, 1.68 equiv) was added dropwise, and the mixture was allowed to warm to room temperature and stirred for 18 hours. The mixture was cooled to 0 °C, quenched with water (60 mL), extracted with DCM (3 x 60 mL), dried with sodium sulfate and the solvent was removed afford compound XV (7.854 g, 128%). Material was used without further purification.
[0194] FIG.10 provides a synthetic scheme for preparation of the following compound: .d XVI: An oven dried 3-necked round bottom flask fitted with a temperature probe, nitrogen inlet, and stir-bar was charged with a diethyl ether (10 vol) solution of 2,3- dibromothiophene (1.5 equiv) and the contents cooled to -78 °C under a flow of nitrogen. n-Butyllithium (2.3 M, 1.54 equiv) was slowly added, ensuring that the temperature remained below -70 °C. The reaction mixture was stirred at -78 °C for an additional 60 minutes. A pre- stirred THF (10 vol) solution of ZnCl2 (2.0 equiv) was slowly added over 10 minutes with rapid stirring while ensuring that the temperature of the reaction mixture did not exceed -65 °C. The mixture was warmed to 0 °C and stirred for 60 minutes, before the reaction mixture was evacuated and purged with nitrogen over 3 cycles, and then canulated to a separate purged vessel containing a solution of dibromobenzothiophene (1.0 equiv) and dppf-PdCl2(0.1 equiv) in THF (5 vol) at room temperature. The reaction mixture was purged with nitrogen before being heated under reflux for 40 hours. After cooling to room temperature, the reaction mixture was treated with aqueous saturated ammonium chloride (5 vol) before being extracted with ethyl acetate (3 x 25 vol), dried over magnesium sulfate, and concentrated under reduced pressure to give 20 g of a dark oil. The crude product was purified by column chromatography and eluted with heptane. Compound XVI was obtained as a white solid (29% yield).
[0196] Compound XVII: Compound XVI (1.0 equiv) was added to an oven-dried 3-neck flask, followed by toluene (610 vol). Sodium tert-butoxide (8.0 equiv) was added then the flask was purged with nitrogen. Pd(dba)2 (0.1 equiv) and dppf (0.2 equiv) were added and the contents degassed for another 3 cycles then stirred at room temperature for 30 mins. Iso- butylamine (1.2 equiv) was then added via syringe and the reaction mixture was stirred at reflux for 15 hours, cooled to ambient temperature, and partitioned between ethyl acetate and water (60 vol). The aqueous layer was extracted with ethyl acetate then organic layers were combined, dried over magnesium sulfate, and concentrated under reduced pressure to give 12 g of a semi- solid which was adsorbed onto silica for purification. The crude product was purified by columnchromatography using Heptane:EtOAc = 5:1 as the eluent. Compound XVII was obtained as a light sensitive yellow oil (3.9 g, 80%) that solidified upon standing.
[0197] Compound XVIII: Compound XVII (1 equiv) was added to an oven dried 3-necked flask under an atmosphere of nitrogen and charged with a THF (80 vol) then cooled to -78 °C. n-Butyllithium (2.3 M, 1.5 equiv) was added, and the contents stirred at this temperature for 60 mins. Tributyltin chloride (3.0 equiv) was added at -70 °C then the reaction temperature was raised to 0 °C and stirred for 18 hours while slowly warming to room temperature. The reaction mixture was then quenched with water (50 vol) and extracted into methyl tertbutyl ether (3 x 100 vol) before being dried over sodium sulfate. The combined organic layers were concentrated to yield compound XVIII (10 g, 127%) as an oil that was later used in additional steps without further purification.
[0198] FIG.11 provides a synthetic scheme for preparation of the following compound:.
[0199] Compound XXI: To a solution of compound XIX (10.0 g, 38.3 mmol, 1 equiv) in DMF (202 mL) was added compound XX (6.77 g, 40.2 mmol, 1.05 equiv) and potassium iodide (1.27 g, 7.66 mmol, 0.20 equiv). The reaction mixture was heated at 80 °C for 1.5 hours then the temperature was increased to 100 °C and stirred for 2 hours at this temperature. Upon completion, the reaction was concentrated at 60 °C to yield compound XXI as a black foam (15.7 g, 100% yield). The black solids were used without further purification.
[0200] Compound XXII: Sodium hydride (806 mg, 60% wt, 20.1 mmol, 1.05 equiv), under nitrogen, was added to an oven dried flask then washed with anhydrous THF (20 mL). DMF (27 mL) was added, and the mixture was stirred until a solution formed. The mixture was cooled in an ice bath for 15 minutes then compound XXI (7.85 g, 19.2 mmol, 1 equiv) in DMF (27 mL) was added dropwise. The reaction mixture was stirred for 15 minutes at 0 °C, then iodoethane (3.14 g, 1.62 mL, 20.1 mmol, 1.05 equiv) was added slowly. The reaction mixture was stirred at 0 °C for 45 minutes then warmed to room temperature. The reaction mixture was stirred at roomtemperature for 45 minutes, resulting in a thick suspension. Additional iodoethane (209 mg, 109 μL, 1.34 mmol, 0.07 equiv) was added and stirred for 1 hour at room temperature. The reaction mixture was filtered, then washed with water (~400 mL) to provide compound XXII as a white solid (5.45 g, 65.0 % yield).
[0201] FIG.12 provides a synthetic scheme for preparation of the following compound: .d XXIII: Compound XVI (8.30 g, 1.00 equiv), sodium tert-butoxide (8.00 equiv), Pd2(dba)3 (0.10 equiv), and dppf (0.20 equiv) were added to an oven dried 3-neck flask. The flask was purged with nitrogen then toluene (60 vol) was charged. The mixture was stirred at room temperature for 30 min then, p-toluidine (1.20 equiv) was charged, and the reaction mixture was stirred at reflux for 18 hours. Upon completion of the reaction, the mixture was cooled to room temperature and partitioned between ethyl acetate and water. The aqueous layer was extracted three times with ethyl acetate then the organic layers were combined, dried over magnesium sulfate, filtered, and concentrated under reduced pressure to a dark oil. The dark oil was purified by column chromatography (10% DCM / heptane) to afford compound XXIII as a light-yellow solid (8.3 g, 79% yield).
[0203] Compound XXIV: A solution of compound XXIII (3.0 g, 1.00 equiv) in THF (0.2 M solution, 15.6 vol) was cooled to -78 °C using an acetone / dry ice bath and then degassed with nitrogen. n-Butyllithium (2.5 M, 1.10 equiv) was added dropwise, ensuring that the internal temperature did not exceed -70 °C. The mixture was kept below -70 °C for 1 hour then tributyltin chloride (1.15 equiv) was added dropwise. The mixture was left to warm to room temperature while stirring for 18 hours. Water was added and the organics were extracted with diethyl ether. The organic layers were combined, dried over sodium sulfate, filtered, and concentrated to yield compound XXIV as a brown oil (200% yield). The resulting material was used without further purification.
[0204] FIG.13A and FIG.13B provides a synthetic scheme for preparation of the following example donor-acceptor-acceptor compounds: , , , , and .
[0205] Compound XXV: Compound XV (7.8 g, 12.47 mmol, 1 equiv) and compound I (3.03 g, 12.47 mmol, 1.0 equiv) were dissolved in toluene (78 mL, 10 vol). Nitrogen was bubbled through the solution for 10 minutes before PdCl2(PPh3)2 (0.63 g, 0.898 mmol, 0.072 equiv) was added and nitrogen was bubbled through the mixture for another 10 minutes. The mixture was heated to reflux and stirred for 18 hours then cooled to room temperature. The solvent was removed to give the crude product as a thick black oil. The crude product was washed with heptane to give a brown solid, which was then purified by column chromatography. The product was eluted with DCM, concentrated, then washed with heptane to give compound XXV as a dark purple solid (3.3067 g, 80% yield).
[0206] Compound XXVI: A dark purple solution of compound XXV (3.3 g, 6.617 mmol, 1.0 equiv) and compound IV (3.3 g, 18.198 mmol, 2.75 equiv) in THF (230 mL, 70 vol) was bubbled with nitrogen for 5 minutes. Piperidine (0.66 mL, 0.2 vol) was added dropwise, turningthe mixture dark red. The solution was stirred at room temperature for 18 hours. The solvent was removed to give the crude product as a solid. The solid was washed with methanol then dried under vacuum to afford compound XXVI as a dark solid (3.7269 g, 85% yield). Compound XXVI was sublimed with 78% yield.
[0207] Compound XXVII: Compound XVIII (10 g, 1.0 equiv, 13.68 mmol) and compound I (0.95 equiv) were combined and taken up in 20 volumes of toluene. The contents were purged and evacuated under nitrogen for 10 minutes, then Pd(PPh3)2Cl2(0.1 equiv, 1.3 mmol) was added and the contents evacuated for 10 mins before the reaction mixture was heated under reflux for 6 hours. The reaction mixture was cooled to room temperature, quenched with aqueous NH4Cl (sat., 50 vol) and extracted with ethyl acetate (3 x 75 vol). The organic layers were combined, dried over magnesium sulfate, filtered, and concentrated to afford a dark residue. The crude material was triturated with heptane and filtered to give 6 g of black solid (97.8% crude yield over two steps). The resulting solid was purified via column chromatography with heptane:DCM as the eluent. Compound XXVII was obtained as a vivid purple solid (4.7 g, 78.3% yield over 2 steps).
[0208] Compound XXVIII: Compound XXVII (1.9 g, 1 equiv) was dissolved in 40 volumes of chloroform. Compound IV (1.5 equiv) was added followed by 2 drops of triethylamine. The reaction mixture was stirred at room temperature for 40 minutes. Once the reaction was complete, the insoluble product was filtered off and washed with methanol to afford compound XXVIII as a green solid (2.37 g, 91% yield). Compound XXVIII was sublimed with 80% yield.
[0209] Compound XXIX: A flask containing 1,4 dioxane (48.0 mL), acetonitrile (48.0 mL), and aqueous potassium carbonate (3.98 g, 28.8 mmol, 1.5 equiv) was sparged with nitrogen gas for 1 hour. The degassed solvent mixture was transferred to a round bottom flask containing compound XXI (7.85 g, 19.2 mmol, 1 equiv). To the mixture was added compound I (4.66 g, 19.2 mmol, 1.00 equiv) and Pd(PPh3)4 (443 mg, 384 μmol, 0.020 equiv) under nitrogen. The mixture was stirred at 80 °C for 24 hours. The reaction was cooled to room temperature and ethyl acetate (50 mL) and water (50 mL) were added, resulting in a suspension. The mixture was filtered, and the resulting solids were washed sequentially with water, NH4Cl, and ethyl acetate to provide compound XXIX (7.3 g, 91% yield).
[0210] Compound XXX: To a solution of compound XXIX (1.76 g, 4.23 mmol, 1 equiv) and compound I (847 mg, 4.65 mmol, 1.10 equiv) in THF was added piperidine (18.0 mg, 211 μmol, 0.05 equiv) (2 drops) and stirred for 2 hours at 40 °C then stirred for 18 hours at room temperature. The mixture was concentrated to 50% volume, then filtered to provide compound XXX (1.55 g, 63.2 % yield) as dark brown solids. Compound XXX did not sublime.
[0211] Compound XXXI: A flask containing 1,4 dioxane (20.0 mL), acetonitrile (20.0 mL), and aqueous potassium carbonate (1.66 g, 12.0 mmol, 1.5 equiv) was purged with nitrogen gas for 1 hour. The degassed solvent mixture was added to compound XXII (3.50 g, 8.00 mmol, 1 equiv). To the mixture was added compound I (1.95 g, 8.00 mmol, 1.00 equiv) and Pd(PPh3)4(185 mg, 160 μmol, 0.020 equiv) under nitrogen. The thick white suspension was stirred at 80 °C for 18 hours then cooled to room temperature and filtered. The resulting solids were washed with water (25 mL) followed by ethyl acetate (40 mL) to provide compound XXXI (2.32 g, 5.22 mmol, 65.2 % yield) as a bright fluorescent orange solid.
[0212] Compound XXXII: To a solution of compound XXXI (1.453 g, 3.269 mmol, 1 equiv) and compound IV (654.9 mg, 3.596 mmol, 1.10 equiv) in DCM (35.53 mL) was added piperidine (13.92 mg, 163.4 μmol, 0.05 equiv). The reaction mixture was stirred for 2 hours at 40 °C then stirred for 18 hours at room temperature. The mixture was concentrated to 50% of its original volume, then filtered to provide compound XXXII (1.35 g, 68% yield) as dark brown solids. Compound XXXII sublimed with 2% yield.
[0213] Compound XXXIII: A solution of compound XXIV (1.14 g, 0.0019 mol, 1.00 equiv) and compound I (0.43 g, 0.0018 mol, 0.95 equiv) in toluene (28.5 mL, 25 vol) was degassed with nitrogen three times with stirring. Following this, Pd(PPh3)2Cl2(0.132 g, 0.0001 mol, 0.10 equiv) was charged and the yellow mixture was heated at reflux for 18 hours. Upon completion of the reaction, the mixture was cooled and concentrated to a residue. The residue was washed with heptane (228 mL, 200 vol). The remaining solids were purified by column chromatography and eluted with heptane:DCM to afford compound XXXIII.
[0214] Compound XXXIV: A solution of compound XXXIII (0.088 g, 0.18 mmol, 1.00 equiv) and compound IV (0.050 g, 0.27 mmol, 1.50 equiv) in chloroform (3.52 mL, 40 vol) was purged with nitrogen for 5 minutes. Triethylamine (a few drops, catalytic) was charged. The solution was stirred at room temperature until reaction completion The suspension was cooledand concentrated to approximately 20% of its original volume. Methanol was charged, and the solids were filtered. The solids were further washed with methanol to yield compound XXXIV as a dark solid.
[0215] FIG.14 provides a synthetic scheme for preparation of the following example donor- acceptor-acceptor compounds: and .
[0216] Compound XXXVI: Compound II (0.5 g, 1.1 equiv) and compound XXXV (1.0 equiv) were charged to a 3-neck flask and dissolved in THF (48 vol). To this solution was added a 2 M solution of potassium carbonate (24 vol), the reaction mixture was then bubbled with nitrogen for 30 mins. Pd(PPh3)4 (0.02 equiv) was added and the reaction mixture was heated and stirred at 70 °C for 24 hours. The reaction mixture was cooled to room temperature then purified by column chromatography. The desired material was eluted with Heptane:DCM to afford compound XXXVI (0.6 g, 69% yield) as a solid.
[0217] Compound XXXVII: Compound XXXVI (0.32 g, 1.0 equiv) and compound IV (2.75 equiv) were charged to a 3-neck flask and dissolved in THF (70 vol) under a nitrogen atmosphere. To the reaction mixture was added piperidine (cat). The reaction mixture was stirred at room temperature until completion then the mixture was concentrated to 20% volume. Methanol was added and the mixture was filtered. The resulting solid was washed with methanol. Compound XXXVII (0.29 g, 67% yield) was obtained as a dark blue solid.
[0218] Compound XXXVIII: Compound XVIII (8.64 mmol, 1.0 equiv), compound XXXV (0.95 equiv), toluene (20 vol) were added to a 3-neck flask. The flask was purged with nitrogen then Pd(PPh3)2Cl2(0.1 equiv) was added and the contents evacuated for 10 mins with before the reaction mixture was heated under reflux for 6 hours. The reaction mixture was cooled to room temperature and washed with sat. NH4Cl. The biphasic mixture was extracted with DCM then the organic layers were combined, dried, filtered, and concentrated under reduced pressure togive the crude product. The resulting material was triturated with heptane to afford compound XXXVIII (2.8 g, 70% yield over two steps) as a solid.
[0219] Compound XXXIX: Compound XXXVIII (2.55 g, 1.0 equiv) and compound IV (1.5 equiv) were charged to a 3-neck flask and dissolved in dichloroethane (140 vol) under a nitrogen atmosphere. To the reaction mixture was added piperidine (cat). The reaction was stirred at 50 °C for 18 hours. The reaction mixture was cooled to room temperature then concentrated to 20% volume. Methanol was added and the mixture was filtered. The resulting solid was washed with methanol. Compound XXXIX (3.21 g, 93% yield) was obtained as a dark solid.
[0220] FIG.15 provides a synthetic scheme for preparation of the following example donor- acceptor-acceptor compounds: , , and .
[0221] Compound XLI: Compound XL (1 g, 1 equiv, 4 mmol), Compound II (3 g, 1.15 equiv, 5 mmol), and Pd(PPh3)2Cl2 (0.03 g, 0.1 equiv, 0.04 mmol) were combined in a 100 mL 3-neck flask followed by 30 mL of toluene. The flask was purged with nitrogen then the reaction mixture was stirred at 110 °C for 2 hours. The reaction mixture was cooled to room temperature then evaporated and dry-loaded onto silica gel for purification. The product was eluted with Heptane:DCM to afford Compound XLI as a dark pink solid (1.26 g, 70% yield).
[0222] Compound XLII: Compound XLI (1.25 g, 1 equiv, 2.98 mmol) and compound IV (1.19 g, 2.2 equiv, 6.56 mmol) were combined in a 250 mL 3-neck flask and taken up in 99 mLof THF. The reaction mixture was degassed and purged with nitrogen then heated to 40 °C. Piperidine (88.8 mg, 103 μL, 0.35 equiv, 1.04 mmol) was added and the reaction mixture was stirred at 40 °C for 4 hours. The mixture was cooled to room temperature and the solvent was evaporated to afford the crude product. The crude material was loaded onto silica gel and purified by column chromatography. The desired product was eluted with Heptane: DCM and concentrated to yield a dark solid 1.55 g (89% yield). The resulting material was further purified by washing with MeOH. The solid was filtered and dried under vacuum to afford compound XLII as a dark blue metallic solid. Compound XLII was sublimed with 77% yield.
[0223] Compound XLIII: Compound XL (0.94 g, 1 equiv, 4 mmol), Compound VI (3 g, 1.15 equiv, 5 mmol), and Pd(PPh3)2Cl2(0.2 g, 0.05 equiv, 0.2 mmol) were combined in a 100 mL 3- neck flask followed by 30 mL of toluene. The flask was purged with nitrogen then the reaction mixture was stirred at 110 °C for 2 hours. The reaction mixture was cooled to room temperature then evaporated and dry-loaded onto silica gel for purification. The product was eluted with Heptane:DCM to afford compound XLIII as a dark purple solid (0.95 g, 50% yield).
[0224] Compound XLIV: Compound XLIII (0.325 g, 1 equiv, 0.76 mmol) and compound IV (0.292 g, 2.1 equiv, 1.6 mmol) were combined in a 100 mL 3-neck flask and taken up in 26 mL of THF. The reaction mixture was degassed and purged with nitrogen then heated to 40 °C. Piperidine (22.8 mg, 26.4 μL, 0.35 equiv, 0.267 mmol) was added and the reaction mixture was stirred at 40 °C for 4 hours. The mixture was cooled to room temperature and the solvent was evaporated to afford the crude product. The crude material was loaded onto silica gel and purified by column chromatography. The desired product was eluted with Heptane:DCM and concentrated to yield compound XLIV as a dark solid (0.342 g, 76% yield). Compound XLIV did not sublime.
[0225] Compound XLV: Compound XVIII (1.0 equiv) and compound XL (0.95 equiv) were combined and taken up in 20 volumes of toluene. The contents were purged and evacuated under nitrogen for 10 minutes, then Pd(PPh3)2Cl2(0.1 equiv, 1.3 mmol) was added and the contents evacuated for 10 mins before the reaction mixture was heated under reflux for 6 hours. The reaction mixture was cooled to room temperature, quenched with aqueous NH4Cl (sat., 50 vol) and extracted with ethyl acetate (3 x 75 vol). The organic layers were combined, dried over magnesium sulfate, filtered, and concentrated to afford a dark residue. The crude material wastriturated with heptane and filtered to give 6 g of black solid (97.8% crude yield over two steps). The resulting solid was purified via column chromatography with heptane:DCM as the eluent.
[0226] Compound XLVI: Compound XLV (1.0 equiv) was dissolved in 40 volumes of chloroform. Compound IV (1.5 equiv) was added followed by 2 drops of triethylamine. The reaction mixture was stirred at room temperature for 40 minutes. Once the reaction was complete, the insoluble product was filtered off and washed with methanol to afford compound XLVI as a solid.
[0227] FIG.16 provides a synthetic scheme for preparation of the following example donor- acceptor-acceptor compounds: nd
[0228] Compound XLVIII: Compound III (2 g, 5 mmol, 1.0 equiv) and compound XLVII (1 g, 7 mmol, 1.5 equiv) were combined in a 500 mL 3-neck flask. THF (0.2 L) was added, and the mixture was heated to 40 °C. Piperidine (0.1 g, 2 mmol, 0.35 equiv) was added and the reaction mixture was stirred at 40 °C for 18 hours. The mixture was cooled to room temperature and the solvent was evaporated to afford the crude product as a dark solid. Crude material was purified by column. The pure product was eluted with DCM. Compound XLVIII (1.7 g, 60% yield) was obtained as a dark blue solid. Compound XLVIII was sublimed with 61% yield.
[0229] Compound L: Compound III (2 g, 5 mmol, 1.0 equiv) and compound XLIX (2 g, 0.01 mol, 2.1 equiv) were combined in a 500 mL 3-neck flask. THF (0.2 L) was added, and the mixture was heated to 40 °C. Piperidine (0.1 g, 2 mmol, 0.35 equiv) was added and the reaction mixture was stirred at 40 °C for 18 hours. The mixture was cooled to room temperature and the solvent was evaporated to afford the crude product as a dark solid. Crude material was purified by column. The pure product was eluted with DCM. Compound L (2.54 g, 90% yield) was obtained as a dark blue solid. Compound L was sublimed with 82% yield.
[0230] Compound LII: Compound III (2 g, 5 mmol, 1.0 equiv) and compound LI (2 g, 0.01 mol, 2.1 equiv) were combined in a 500 mL 3-neck flask. THF (0.2 L) was added, and the mixture was heated to 40 °C. Piperidine (0.1 g, 2 mmol, 0.35 equiv) was added and the reaction mixture was stirred at 40 °C for 18 hours. The mixture was cooled to room temperature and the solvent was evaporated to afford the crude product as a dark solid. Crude material was triturated with methanol and filtered to afford compound LII as a dark solid. Compound LII was sublimed with 28% yield. EXAMPLE 2 – OPTICAL PROPERTIES OF EXAMPLE DONOR-ACCEPTOR-ACCEPTOR COMPOUNDS
[0231] The following donor-acceptor-acceptor compounds were evaluated for their optical activity: V, VIII, XI, XXVI, XXVIII, XXX, XXXII, XXXIX, XLII, XLIV, XLVIII, L, and LII.
[0232] Table 1 provides an overview of different components of various donor-acceptor- acceptor compounds evaluated for optical activity to show thematic differences explored between donor D, acceptor A1, and acceptor A2moieties, and comparison with the structures of several reference compounds.
[0233] As an example, compounds V, VIII, XI, XXVI, XXVIII, XXX, and XXXII include the same acceptor A2moiety as each other, the same acceptor A1moiety as each other, but different donor D moieties from each other. As another example, compounds XLII and XLIV include the same acceptor A1moiety as each other (though different from the previous example), the same acceptor A2moiety as each other, different donor D moieties from each other. As another example, compounds V and XLII include the same donor D moiety as each other, the same acceptor A2moiety as each other, but different acceptor A1moieties from each other. Similarly, as another example, compounds VIII and XLIV include the same donor D moiety as each other, the same acceptor A2moiety as each other, but different acceptor A1moieties from each other.
[0234] FIG.17A provides spectra (in dichloromethane) for compounds V, VIII, and XI. FIG. 17B provides spectra (in dichloromethane) for compounds XXVI, XXXVIII, XXX, and XXXII. FIG.17C provides thin film spectra for compounds V, VIII, XXVI, and XXVIII. Absorption coefficients were measured through spectroscopic ellipsometry of vacuum thermal evaporated films.
[0235] FIG.18A provides spectra (in dichloromethane) for compound XXXIX. FIG.18B provides spectra (in dichloromethane) for compounds XLII and XLIV. FIG.18C provides thin film spectra for compounds XLII and XLIV. Absorption coefficients were measured through spectroscopic ellipsometry of vacuum thermal evaporated films.
[0236] FIG.19A provides spectra (in dichloromethane) for compounds XLVIII, L, and LII. FIG.19B provides thin film spectra for compounds L and LII. Absorption coefficients were measured through spectroscopic ellipsometry of vacuum thermal evaporated films. EXAMPLE 3 – COMPARATIVE DATA FOR PHOTOVOLTAIC DEVICES INCORPORATING DONOR-ACCEPTOR-ACCEPTOR COMPOUNDS
[0237] A comparative study was undertaken to compare the stability of the donor-acceptor- acceptor compounds incorporating or as terminal acceptor (A2) moiety and comparison with other donor-acceptor-acceptor compounds.
[0238] The following comparative photoactive compound, including a dicyano-based terminal acceptor (A2), was incorporated into a comparative photovoltaic device stack to evaluate photovoltaic performance and stability characteristics: (DTDCTB). DTDCTB was used in a mixed heterojunction layer with C70, with the mixed heterojunction layer comprising about 40% DTDCTB and about 60% C70 by volume. Further details of the device stack configuration are depicted in FIG.20A.
[0239] The following comparative photoactive compound, including a dicyano-based acceptor moiety A2, was incorporated into a comparative photovoltaic device stack to evaluate photovoltaic performance and stability characteristics: (DTDCPB). DTDCPB was used in a mixed heterojunction layer with C70, with the mixed heterojunction layer comprising about 25% DTDCPB and about 75% C70by volume Further details of the device stack configuration are depicted in FIG 20B
[0240] The following comparative photoactive compound, including a dicyano-based acceptor moiety A2, was incorporated into a comparative photovoltaic device stack to evaluate photovoltaic performance and stability characteristics: (iBuBTDC). iBuBTDC was used in a mixed heterojunction layer with C70, with the mixed heterojunction layer comprising about 30% iBuBTDC and about 70% C70 by volume. Further details of the device stack configuration are depicted in FIG.20C.
[0241] The following photoactive compound was prepared, including an indandione-based acceptor moiety A2, and incorporated into a photovoltaic device stack to evaluate preliminary photovoltaic and optical properties: (Compound V). Compound V was used in a mixed heterojunction layer with C70, with the mixed heterojunction layer comprising about 25% compound V and about 75% C70by volume. Further details of the device stack configuration are depicted in FIG.21A.
[0242] The following photoactive compound was prepared and incorporated into a photovoltaic device stack to evaluate preliminary photovoltaic and optical properties: (Compound XI). Compound XI was used in a mixed heterojunction layer with C70, with the mixed heterojunction layer comprising about 30%compound XI and about 70% C70 by volume. Further details of the device stack configuration are depicted in FIG.21B.
[0243] DTDCTB is directly comparable with compound VIII, which includes the same donor D moiety and acceptor A1moiety, but a different acceptor A2moiety. Additionally, DTDCTB is comparable with compound XLIV, which includes the same donor D moiety as DTDCTB, but a different acceptor A1moiety and acceptor A2moiety. Compounds VIII and XLIV include the same donor D moiety and acceptor A2moiety as each other, but different acceptor A1moieties.
[0244] DTDCPB is directly comparable with compounds V, XLVIII, L, and LII, which include the same donor D moiety and acceptor A1moiety as DTDCPB, but different acceptor A2moieties. Additionally, DTDCTB is comparable with compound XLII, which includes the same donor D moiety as DTDCTB, but a different acceptor A1moiety and acceptor A2moiety. Compounds V, XLVIII, L, and LII include the same donor D moiety and acceptor A2moiety as each other, but different acceptor A1moieties.
[0245] iBuBTDC is directly comparable with compound XXVIII, which includes the same donor D moiety and acceptor A1moiety as iBuBTDC, but a different acceptor A2moiety. Additionally, iBuBTDC is comparable with compound XXXIX, which includes the same donor D moiety as iBuBTDC, but a different acceptor A1moiety and acceptor A2moiety. Compounds XXVIII and XXXIX include the same donor D moiety and acceptor A2moiety as each other, but different acceptor A1moieties.
[0246] The devices were evaluated to determine their performance characteristics and stability for exposure to simulated solar radiation for a period of up to about 1300 hours. FIG.22 and FIG.23 provides normalized short circuit current (JSC) for the devices as a function of operational time. FIG.24 and FIG.25 provide normalized open circuit voltage (VOC) for the devices as a function of operational time. FIG.26 and FIG.27 provide normalized fill factors (FF) for the devices as a function of operational time. FIG.28 and FIG.29 provide normalized power conversion efficiency (PCE) for the devices as a function of operational time.
[0247] FIG.30A, FIG.30B, and FIG.30C respectively provide current-voltage (J-V) curves for the devices depicted in FIG.20A, FIG.20B, and FIG.20C, showing curves for devices at initial operation (0 hrs) and devices operated for a long duration (over 1200 hours) SimilarlyFIG.31A and FIG.31B respectively provide current-voltage (J-V) curves for the devices depicted in FIG.21A and FIG.21B, showing curves for devices at initial operation (0 hrs) and devices operated for a long duration (over 1200 hours).
[0248] Based on FIGS.22-23, the short circuit currents of the devices including the reference compounds DTDCTB, DTDCPB, and iBuBTDC show a degradation to below about 70% of their initial short circuit currents by about 1200 hours; in contrast, the devices including the inandione-containing compounds V and XXVIII, surprisingly and unexpectedly, exhibited very stable short circuit currents, degrading less than 10% by about 1200 hours.
[0249] Based on FIG.24-25, the open circuit voltages of the devices including the reference compounds DTDCTB, DTDCPB, and iBuBTDC show a degradation to below about 95% of their initial open circuit voltages by about 1200 hours; in contrast, the devices including the inandione-containing compounds V and XXVIII, surprisingly and unexpectedly, exhibited very stable open circuit voltages, degrading less than 1% by about 1200 hours.
[0250] Based on FIG.26-27, the fill factors of the devices including the reference compounds DTDCTB, DTDCPB, and iBuBTDC show a degradation to below about 75% of their initial fill factors by about 1200 hours; in contrast, the devices including the indandione-containing compounds V and XXVIII, surprisingly and unexpectedly, exhibited very stable fill factors, degrading less than 5% by about 1200 hours.
[0251] Based on FIG.26-27, the power conversion efficiency of the devices including the reference compounds DTDCTB, DTDCPB, and iBuBTDC show a degradation to below about 40% of their power conversion efficiencies by about 1200 hours; in contrast, the devices including the inandione-containing compounds V and XXVIII, surprisingly and unexpectedly, exhibited very stable power conversion efficiencies, degrading less than 10% by about 1200 hours.
[0252] Initial average visible transparency (Tvis) was assessed to demonstrate the transparency of the photovoltaic devices reported. The time to a 20% reduction in average power conversion efficiency (T80) were also evaluated for the devices. T80 is a commonly used metric to assess the time-to-failure for photovoltaic device performance, where devices exhibiting an average efficiency below 80% of their initial value are deemed as having “failed”
[0253] Table 2 provides a summary of the performance of the devices, including short circuit current (JSC), open circuit voltage (VOC), fill factor (FF), power conversion efficiency (PCE), initial visible transparency (Tvis), and time to a 20% reduction in average power conversion efficiency (T80).
[0254] These results indicate the devices including D-A1-A2compounds where A2is an inandione moiety exhibit strong stability, with limited degradation over long durations, indicating these molecules exhibit superior stability and performance in comparison to devices incorporating DTDCTB, DTDCPB, or iBuBTDC. These results are surprising and unexpected in that DTDCTB, DTDCPB, or iBuBTDC may correspond to state-of-the-art reference D-A1-A2type compounds that generally exhibit good initial performance, and it is not clear that a change of the composition of the terminal acceptor moiety (A2) to a difluoro-indandione moiety wouldcharacteristics (e.g., JSC, VOC, FF, PCE, Tvis) for the devices containing the reference compounds and the inventive compounds V and XXVIII are nearly identical.
[0255] DTDCTB, DTDCPB, and iBuBTDC were selected as comparatives as these compounds represent good performing donor materials for small molecule organic solar cells. Further details regarding DTDCTB, DTDCPB, iBuBTDC, and other comparative compounds are described in Chen et al., 2012, “Deposited Small-Molecule Organic Solar Cells with High Power Conversion Efficiencies by Judicious Molecular Design and Device Optimization,” Journal of the American Chemical Society, 134, 13616-13623, DOI: 10.1021 / ja301872s, and Che et al., 2018, “Donor–Acceptor–Acceptor’s Molecules for Vacuum-Deposited Organic Photovoltaics with Efficiency Exceeding 9%,” Adv. Energy Mater., 1703603, DOI: 10.1002 / aenm.201703603, hereby incorporated by reference. EXAMPLE 4 – SYNTHESIS OF EXAMPLE DONOR-ACCEPTOR-ACCEPTOR COMPOUNDS
[0256] FIGS.32-48 provide an overview of various example synthetic schemes providing synthetic routes for various compounds, including a number of donor-acceptor-acceptor compounds.
[0257] FIG.32 provides a synthetic scheme for preparation of the following compound: .
[0258] Compound LIII: 6-bromo-2-naphthol and p-toluidine are combined in the presence of p-toluenesulfonic acid to generate compound LIII.
[0259] Compound LIV: Compound LII is added to a mixture of copper, potassium carbonate and 18-crown-6, followed by addition 4-iodotoluene to generate compound LIV.
[0260] Compound LV: Compound LIV is dissolved in THF and n-butyllithium is added, followed by tributyltin chloride to generate compound LV
[0261] FIG.33 provides a synthetic scheme for preparation of the following compound: .
[0262] Compound LVI: 2-iodothioenothiophene (3-iodo-2,6-dithiabicyclo[3.3.0]octa-1(5),3,7- triene) is added to 1,10-phenanthroline and combined with a mixture of potassium hydroxide, copper iodide, and xylene, followed by addition bis(p-tolyl)amine to generate compound LVI.
[0263] Compound LVII: Compound LVI is dissolved in THF and n-butyllithium is added, followed by tributyltin chloride to generate compound LVII.
[0264] FIG.34 provides a synthetic scheme for preparation of the following compound: .
[0265] Compound LVIII: 2-bromo-1-methylpyrrole is added to toluene and sodium tert- butoxide is added. Pd(dba)2and dppf are then added to the mixture, followed by bis(p- tolyl)amine, then N-bromosuccinimide (NBS) to generate compound LVIII.
[0266] Compound LIX: Compound LVIII is dissolved in THF and n-butyllithium is added, followed by tributyltin chloride to generate compound LIX.
[0267] FIG.35 provides a synthetic scheme for preparation of the following compound:
[0268] Compound LX: 2,5-dibromo-1-methylimidazole is added to toluene and sodium tert- butoxide is added. Pd(dba)2 and dppf are added to the mixture, followed by bis(p-tolyl)amine to generate compound LVIII.
[0269] Compound LXI: Compound LX is dissolved in THF and n-butyllithium is added, followed by tributyltin chloride to generate compound LXI.
[0270] FIG.36 provides a synthetic scheme for preparation of the following compound: .
[0271] Compound LXIII: Compound LXII and triethyl(ethynyl)silane are combined in a mixture with Pd(PPh3)2Cl2, copper (I) iodide, and triethylamine. Following this, the mixture is combined with a solution of tetrabutyl ammonium fluoride in THF to generate compound LXIII.
[0272] FIG.37 provides a synthetic scheme for preparation of the following compound: .
[0273] Compound LXIV: 1,3-dibromo-2-thia-4,7-diazaindene is added to toluene and sodium tert-butoxide is added. Pd(dba)2and dppf are added to the mixture, followed by bis(p- tolyl)amine to generate compound LXIV.
[0274] Compound LXV: Compound LXIV is dissolved in THF and n-butyllithium is added, followed by tributyltin chloride to generate compound LXV.
[0275] FIG.38 provides a synthetic scheme for preparation of the following compound: .
[0276] Compound LXVI: 1,3-dibromo-2-benzothiophene is added to toluene and sodium tert- butoxide is added. Pd(dba)2 and dppf are added to the mixture, followed by bis(p-tolyl)amine to generate compound LXIV.
[0277] Compound LXVII: Compound LXVI is dissolved in THF and n-butyllithium is added, followed by tributyltin chloride to generate compound LXVII.
[0278] FIG.39 provides a synthetic scheme for preparation of the following compound: .
[0279] Compound LXIX: 2,3-dibromothiophene is dissolved in a diethyl ether solution and n- butyllithium is added. A solution of ZnCl2 in THF is then added. The mixture is then combined with a solution of compound LXVIII and dppf-PdCl2 in THF to generate compound LXIX.
[0280] Compound LXX: Compound LXIX is added to toluene and sodium tert-butoxide is added. Pd(dba)2 and dppf are added to the mixture, followed by Iso-butylamine to generate compound LXX.
[0281] Compound LXXI: Compound LXX is dissolved in THF and n-butyllithium is added, followed by tributyltin chloride to generate compound LXXI.
[0282] FIG.40 provides a synthetic scheme for preparation of the following compound: .
[0283] Compound LXXII: Methyl o-iodobenzoate and aniline are combined in the presence of potassium carbonate, copper, and copper iodide to generate compound LXXII.
[0284] Compound LXXIII: Compound LXXII is exposed to methyllithium in diethyl ether to generate compound LXXIII.
[0285] Compound LXXIV: Compound LXXIII is exposed to phosphoric acid to generate compound LXXIV.
[0286] Compound LXXV: Compound LXXIV is exposed to n-bromosuccinimide to generate compound LXXV.
[0287] Compound LXXVI: Compound LXXV is dissolved in THF and n-butyllithium is added, followed by tributyltin chloride to generate compound LXXVI.
[0288] FIG.41 provides a synthetic scheme for preparation of the following compound: .
[0289] Compound LXXVII: 5-Bromo-2-iodopyrimidine is added to toluene and sodium tert- butoxide is added. Pd(dba)2 and dppf are added to the mixture, followed by bis(p-tolyl)amine to generate compound LXIV.
[0290] Compound LXXVIII: Compound LXXVII is dissolved in THF and n-butyllithium is added, followed by tributyltin chloride to generate compound LXXVIII.
[0291] FIG.42 provides a synthetic scheme for preparation of the following compound:.
[0292] Compound LXXIX: o-Bromoethynylbenzene and b-Bromo-2-iodothiophene are combined in a mixture with Pd(PPh3)2Cl2, copper (I) iodide, and triethylamine to generate compound LXXIX.
[0293] Compound LXXX: Compound LXXIX is added to toluene and sodium tert-butoxide is added. Pd(dba)2and dppf are added to the mixture, followed by p-toluenesulfonamide to generate compound LXIV.
[0294] Compound LXXXI: Compound LXXX is exposed to copper (II) acetate in DMF, followed by exposure to a mixture of hydrogen bromide and acetic acid to generate compound LXXXI.
[0295] Compound LXXXII: Compound LXXXI is exposed to isobutyliodide in the presence of potassium hydroxide to generate compound LXXXII.
[0296] Compound LXXXIII: Compound LXXXII is dissolved in THF and n-butyllithium is added, followed by tributyltin chloride to generate compound LXXXIII.
[0297] FIG.43 provides a synthetic scheme for preparation of the following compound: .
[0298] Compound LXXXV: Compound LXXXIV is exposed to n-bromosuccinimide to generate compound LXXXV.
[0299] Compound LXXXVI: Compound LXXXV is exposed to formic acid to generate compound LXXXVI.
[0300] Compound LXXXVII: Compound II and compound LXXXVI are combined in toluene and Pd(PPh3)Cl2 is added to generate compound LXXXVII.
[0301] FIG.44 provides a synthetic scheme for preparation of the following compound: .XXVIII: 4-bromo-2,3-toluenediamine is mixed with 1,1'-carbonyldiimidazole in DMF to generate compound LXXXVIII.
[0303] Compound LXXXIX: Compound LXXXVIII is exposed to manganese dioxide in DCM to generate compound LXXXIX.
[0304] Compound XC: Compound LXXXIX is exposed to n-bromosuccinimide to generate compound XC.
[0305] Compound XCI: Compound XC is exposed to formic acid to generate compound XCI.
[0306] Compound XCII: Compound II and compound XCI are combined in toluene and Pd(PPh3)Cl2is added to generate compound XCII.
[0307] FIG.45 provides a synthetic scheme for preparation of the following example donor- acceptor-acceptor compounds:, , , and .
[0308] Compound XCIII: Compound I and compound LV are combined in toluene and Pd(PPh3)Cl2is added to generate compound XCIII.
[0309] Compound XCIV: Compound XCIII and compound IV are combined in THF and piperidine is added to generate compound XCIV.
[0310] Compound XCV: Compound I and compound LVII are combined in toluene and Pd(PPh3)Cl2 is added to generate compound XCV.
[0311] Compound XCVI: Compound XCV and compound IV are combined in THF and piperidine is added to generate compound XCVI.
[0312] Compound XCVII: Compound I and compound LIX are combined in toluene and Pd(PPh3)Cl2 is added to generate compound XCVII.
[0313] Compound XCVIII: Compound XCVII and compound IV are combined in THF and piperidine is added to generate compound XCVIII.
[0314] Compound XCIX: Compound I and compound LXI are combined in toluene and Pd(PPh3)Cl2is added to generate compound XCVII.
[0315] Compound C: Compound XCIX and compound IV are combined in THF and piperidine is added to generate compound C.
[0316] FIG.46 provides a synthetic scheme for preparation of the following example donor- acceptor-acceptor compounds: , , , and .
[0317] Compound CI: Compound I and compound LXIII are combined in a mixture with Pd(PPh3)2Cl2, copper (I) iodide, and triethylamine to generate compound CI.
[0318] Compound CII: Compound CI and compound IV are combined in THF and piperidine is added to generate compound CII.
[0319] Compound CIII: Compound I and compound LXV are combined in toluene and Pd(PPh3)Cl2 is added to generate compound CIII.
[0320] Compound CIV: Compound CIII and compound IV are combined in THF and piperidine is added to generate compound CIV.
[0321] Compound CV: Compound I and compound LXVII are combined in toluene and Pd(PPh3)Cl2 is added to generate compound CV.
[0322] Compound CVI: Compound CV and compound IV are combined in THF and piperidine is added to generate compound CVI.
[0323] Compound CVII: Compound I and compound LXXI are combined in toluene and Pd(PPh3)Cl2is added to generate compound CVII
[0324] Compound CVIII: Compound CVII and compound IV are combined in THF and piperidine is added to generate compound CVIII.
[0325] FIG.47 provides a synthetic scheme for preparation of the following example donor- acceptor-acceptor compounds: , , and .
[0326] Compound CIX: Compound I and compound LXXVI are combined in toluene and Pd(PPh3)Cl2 is added to generate compound CIX.
[0327] Compound CX: Compound CX and compound IV are combined in THF and piperidine is added to generate compound CXI.
[0328] Compound CXI: Compound I and compound LXXVIII are combined in toluene and Pd(PPh3)Cl2is added to generate compound CXI.
[0329] Compound CXII: Compound CXI and compound IV are combined in THF and piperidine is added to generate compound CXII.
[0330] Compound CXIII: Compound I and compound LXXXIII are combined in toluene and Pd(PPh3)Cl2is added to generate compound CXIII.
[0331] Compound CXIV: Compound CXIII and compound IV are combined in THF and piperidine is added to generate compound CXIV.
[0332] FIG.48 provides a synthetic scheme for preparation of the following example donor- acceptor-acceptor compounds: and .
[0333] Compound CXV: Compound LXXXVII and compound IV are combined in THF and piperidine is added to generate compound CXV.
[0334] Compound CXVI: Compound XCII and compound IV are combined in THF and piperidine is added to generate compound CXVI. STATEMENTS REGARDING INCORPORATION BY REFERENCE AND VARIATIONS
[0335] All references throughout this disclosure, for example patent documents including issued or granted patents or equivalents; patent application publications; and non-patent literature documents or other source material; are hereby incorporated by reference herein in their entireties, as though individually incorporated by reference.
[0336] All patents and publications mentioned in this disclosure are indicative of the levels of skill of those skilled in the art to which the invention pertains. References cited herein are incorporated by reference herein in their entirety to indicate the state of the art, in some cases as of their filing date, and it is intended that this information can be employed herein, if needed, to exclude (for example, to disclaim) specific embodiments that are in the prior art. For example, when a compound is claimed, it should be understood that compounds known in the prior art, including certain compounds disclosed in the references disclosed herein (particularly in referenced patent documents), are not intended to be included in the claim.
[0337] When a group of substituents is disclosed herein, it is understood that all individual members of those groups and all subgroups and classes that can be formed using the substituents are disclosed separately. When a Markush group or other grouping is used herein, all individualmembers of the group and all combinations and subcombinations possible of the group are intended to be individually included in the disclosure. As used herein, “and / or” means that one, all, or any combination of items in a list separated by “and / or” are included in the list; for example “1, 2 and / or 3” is equivalent to “’1’ or ‘2’ or ‘3’ or ‘1 and 2’ or ‘1 and 3’ or ‘2 and 3’ or ‘1, 2 and 3’”.
[0338] Every formulation or combination of components described or exemplified can be used to practice the invention, unless otherwise stated. Specific names of materials are intended to be exemplary, as it is known that one of skill in the art can name the same material differently. It will be appreciated that methods, device elements, starting materials, and synthetic methods other than those specifically exemplified can be employed in the practice of the invention without resort to undue experimentation. All art-known functional equivalents, of any such methods, device elements, starting materials, and synthetic methods are intended to be included in this disclosure. Whenever a range is given in the specification, for example, a temperature range, a time range, or a composition range, all intermediate ranges and subranges, as well as all individual values included in the ranges given are intended to be included in the disclosure.
[0339] As used herein, “comprising” is synonymous with “including,” “containing,” or “characterized by,” and is inclusive or open-ended and does not exclude additional, unrecited elements or method steps. As used herein, “consisting of” excludes any element, step, or ingredient not specified in the claim element. As used herein, “consisting essentially of” does not exclude materials or steps that do not materially affect the basic and novel characteristics of the claim. Any recitation herein of the term “comprising”, particularly in a description of components of a composition or in a description of elements of a device, is understood to encompass those compositions and methods consisting essentially of and consisting of the recited components or elements. The invention illustratively described herein suitably may be practiced in the absence of any element or elements, limitation or limitations which is not specifically disclosed herein.
[0340] Abbreviations that may be utilized in the present specification include: ITO: Indium tin oxide MoO3: Molybdenum trioxideZnO: Zinc oxide SubNc: Boron sub-2,3-naphthalocyanine chloride SubPc: Boron subphthalocyanine chloride TPBi: 2,2′,2"-(1,3,5-Benzinetriyl)-tris(1-phenyl-1-H-benzimidazole) C60: Fullerene-C60 C70: Fullerene-C70p-6P: Para-sexiphenyl HAT-CN: Dipyrazino[2,3-f:2',3'-h]quinoxaline-2,3,6,7,10,11-hexacarbonitrile DTDCTB: 2-((7-(5-(Di-p-tolylamino)thiophen-2-yl)benzo[c][1,2,5]thiadiazol-4- yl)methylene)malononitrile DTDCPB: 2-((7-(4-(Di-p-tolylamino)phenyl)benzo[c][1,2,5]thiadiazol-4- yl)methylene)malononitrile iBuBTDC: 2-((7-(N-(isobutyl)-benzothieno[3,2-b]thieno[2,3-d]-pyrrol-2- yl)benzo[c][1,2,5]thiadiazol-4-yl)methylene)malononitrile THF: tetrahydrofuran DCM: dichloromethane DCE: 1,2-dichloroethane Ph: phenyl (-C6H5) Me: methyl (-CH3) Et: ethyl (-CH2CH3) Ac: acetyl (-C(=O)-CH3) Bu: butyl (-C4H9, e.g., n-butyl, sec-butyl, isobutyl, tert-butyl, etc.) dba: dibenzylideneacetonedppf: 1,1′-Bis(diphenylphosphino)ferrocene
[0341] The terms and expressions which have been employed are used as terms of description and not of limitation, and there is no intention in the use of such terms and expressions of excluding any equivalents of the features shown and described or portions thereof, but it is recognized that various modifications are possible within the scope of the invention claimed. Thus, it should be understood that although the present invention has been specifically disclosed by preferred embodiments and optional features, modification and variation of the concepts herein disclosed may be resorted to by those skilled in the art, and that such modifications and variations are considered within the scope of this disclosure as defined by the appended claims.
Claims
WHAT IS CLAIMED IS:
1. A photoactive compound having the formula: D–A1–A2, D–pi–A1–A2, D–A1–pi–A2, or D–pi–A1–pi–A2, wherein A1and A2are electron acceptor moieties, wherein A2comprises or , wherein D is an electron donor moiety, wherein pi is a π-bridging moiety, wherein Ar is an aromatic, heteroaromatic, fused-ring aromatic, or fused-ring heteroaromatic aromatic group having one or more substituents R, wherein each R is H, F, Cl, Br, I, CH3, CF3, CF2H, CFH2, CCl3, or CN or wherein R and R form a ring, wherein each Y1is independently C(CN)2, O, S, or cyanoimine, and wherein Y2is CH or N.
2. The photoactive compound of claim 1, wherein A2comprises or has a formula: , , , , , , , , , or .
3. The photoactive compound of claim 1, wherein A2comprises a substituted or unsubstituted indandione, a substituted or unsubstituted indandithione, a substituted or unsubstituted dicyanomethyleneindanone, or a substituted or unsubstituted bis(dicyanomethylidene)indan.
4. The photoactive compound of claim 1, wherein A2comprises a fused-aryl indandione, a fused-aryl indandithione, a fused-aryl dicyanomethyleneindanone, or a fused-aryl bis(dicyanomethylidene)indan.
5. The photoactive compound of claim 1, wherein A2comprises or has a formula: , , , , , , , , , , , , , , , , , or .
6. The photoactive compound of claim 1, wherein A2comprises or has a formula: , , , , , , , 99,7. The photoactive compound of claim 1, wherein Ar comprises a substituted or unsubstituted heterocycle.
8. The photoactive compound of claim 1, wherein Ar comprises one or more five-membered or six-membered aromatic rings having one or more substituents R.
9. The photoactive compound of claim 1, having a molecular weight of from 250 atomic mass units to 900 atomic mass units.
10. The photoactive compound of claim 1, characterized by or exhibiting a decomposition rate at particular temperature that is lower than an evaporation or sublimation rate at the particular temperature, wherein the particular temperature is from 150 °C to 400 °C.
11. The photoactive compound of claim 1, characterized by or exhibiting a vapor pressure between 10-6Torr and 1 Torr at temperatures from 150 °C to 400 °C12. The photoactive compound of claim 1, exhibiting a bandgap of 0.5 eV to 2.5 eV.
13. The photoactive compound of claim 1, wherein D comprises or has a formula: , , , , , , , , , , , , , , , , , , or , wherein each R is independently H, F, Cl, Br, I, CH3, CF3, CF2H, CFH2, CCl3, OCH3 or CN, wherein each X is independently O, S, Se, NH, NRN, CH2, C(RN)2, Si(RN)2, or Ge(RN)2, wherein each Ar is independently a fused or unfused aromatic or heteroaromatic group including one or more R group substituents, wherein ring B is a cycloalkyl or cycloalkenyl group having from 5 to 9 carbon atoms and including one or more R group substituents, wherein RNis a branched, cyclic, or straight chain alkyl group or fluorinated alkyl group having a molecular weight of from 15 amu to 150 amu, wherein each Y3isindependently CH, N, CR or CRN, and wherein R1is an aromatic or heterocyclic ring substituted with H, F, CH3, CF3, CF2H, CFH2, CCl3, CN, or a branched or straight chain alkyl group or fluorinated alkyl group having a molecular weight of from 15 amu to 150 amu.
14. The photoactive compound of claim 1, wherein D comprises or has a formula: , , , , , , , , , , , , , , , , , , , , , ,, , , , , , , , , , or .
15. The photoactive compound of claim 1, wherein A1comprises or has a formula: , , , , , , , , , or , wherein each R is independently H, F, Cl, Br, I, CH3, CF3, CF2H, CFH2, CCl3, OCH3or CN, wherein each X1is independently O, S, Se, C=O, or NRO, and wherein ROis H or a branched or straight chain alkyl group or fluorinated alkyl group having a molecular weight of from 15 amu to 150 amu.
16. The photoactive compound of claim 1, wherein A1comprises or has a formula: , , , , , , , , , , , , , , , , , , or .
17. The photoactive compound of claim 1, wherein each pi independently comprises: , , , , , , , , , , , , , , , , , , , , , , ,, , or , wherein each X1is independently O, S, Se, C=O, or NRN, wherein each R is independently H, F, Cl, Br, I, CH3, OCH3, CF3, CF2H, CFH2, CCl3, or CN, wherein each X2is independently O, S, Se, NH, NRN, CH2, or C(RN)2, wherein each W is independently H, F, or a branched or straight chain C1-C8 alkyl group or a branched or straight chain C1-C8 alkoxy group, and wherein each RNis independently a branched, cyclic, or straight chain alkyl or fluorinated alkyl or ester group having a molecular weight of from 15 amu to 150 amu.
18. The photoactive compound of claim 1, wherein the D and A1moieties are connected by a single bond or a double bond, wherein the A1and A2moieties are connected by a single bond or a double bond, wherein the D and pi moieties are connected by a single bond or a double bond, wherein the A1and pi moieties are connected by a single bond or a double bond, or wherein the pi and A2moieties are connected by a single bond or a double bond.
19. The photoactive compound of claim 1, having a formula of , , , , , , , , ,, , , , , , or .
20. The photoactive compound of claim 1, wherein the D and A1moieties are fused together or wherein the D and A1moieties are fused together by way of one or more aryl or heteroaryl groups.
21. The photoactive compound of claim 20, wherein the D and A1together comprise or have a formula of: , , , or .
22. The photoactive compound of claim 20, having a formula of: , , , , , or .
23. A photovoltaic device comprising: a substrate; a first electrode coupled to the substrate; a second electrode above the first electrode; a first photoactive layer between the first electrode and the second electrode, wherein the first photoactive layer comprises the photoactive compound of claim 1; and a second photoactive layer between the first electrode and the second electrode, wherein the second photoactive layer comprises a counterpart electron donor material or a counterpart electron acceptor material, and wherein the first photoactive layer and the second photoactive layer correspond to separate photoactive layers, partially mixed photoactive layers, or a fully mixed photoactive layer.
24. The photovoltaic device of claim 23, wherein one or more or all of the substrate, the first electrode, the second electrode, the first photoactive layer, or the second photoactive layer is visibly transparent.
25. The photovoltaic device of claim 23, wherein one or more of the substrate, the first electrode, the second electrode, the first photoactive layer, or the second photoactive layer is partially transparent or opaque.
26. The photovoltaic device of claim 23, wherein the photoactive compound of claim 1 is an electron acceptor compound and wherein the second photoactive layer comprises a counterpart electron donor material.
27. The photovoltaic device of claim 23, wherein the photoactive compound of claim 1 is an electron donor compound and wherein the second photoactive layer comprises a counterpart electron acceptor material.
28. A method of making a photovoltaic device, the method comprising: providing a substrate; providing a first electrode coupled to the substrate; depositing a photoactive layer over the first electrode and substrate by a vapor deposition technique, the photoactive layer comprising the photoactive compound of claim 1; and providing a second electrode over the photoactive layer.
29. The method of claim 28, wherein depositing the photoactive layer comprises depositing the photoactive compound using a thermal evaporation process.
30. The method of claim 28, wherein one or more or all of the substrate, the first electrode, the second electrode, or the photoactive layer is visibly transparent.
31. The method of claim 28, wherein one or more of the substrate, the first electrode, the second electrode, or the photoactive layer is partially transparent or opaque.
Citation Information
Patent Citations
PHOTOACTIVE ORGANIC COMPOUND
FR3011548A1
Tunable Photoactive Compounds
US20140261692A1
Visibly transparent photoactive compounds for near-infrared-absorbing photovoltaic devices
US20210184145A1
